<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Nutr.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Nutrition</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Nutr.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2296-861X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fnut.2026.1779927</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Targeting ferroptosis with culinary spices: a dietary strategy for neuroprotection via the Nrf2/GPX4 axis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Hong</surname>
<given-names>Wei</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Qing</surname>
<given-names>Yingjie</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2911793"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Liu</surname>
<given-names>Jie</given-names>
</name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/3336527"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label><institution>State Key Laboratory of Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, Nanjing University of Chinese Medicine</institution>, <city>Nanjing</city>, <country country="cn">China</country></aff>
<aff id="aff2"><label>2</label><institution>School of Pharmacy, Nanjing University of Chinese Medicine</institution>, <city>Nanjing</city>, <country country="cn">China</country></aff>
<aff id="aff3"><label>3</label><institution>Department of Pharmacy, Nanjing Pukou People&#x2019;s Hospital, Liangjiang Hospital, Southeast University</institution>, <city>Nanjing</city>, <country country="cn">China</country></aff>
<author-notes>
<corresp id="c001"><label>&#x002A;</label>Correspondence: Yingjie Qing, <email xlink:href="mailto:qingyingjie@njucm.edu.cn">qingyingjie@njucm.edu.cn</email>; Jie Liu, <email xlink:href="mailto:15358112838@163.com">15358112838@163.com</email></corresp>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-02-12">
<day>12</day>
<month>02</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2026</year>
</pub-date>
<volume>13</volume>
<elocation-id>1779927</elocation-id>
<history>
<date date-type="received">
<day>03</day>
<month>01</month>
<year>2026</year>
</date>
<date date-type="rev-recd">
<day>22</day>
<month>01</month>
<year>2026</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>01</month>
<year>2026</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2026 Hong, Qing and Liu.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>Hong, Qing and Liu</copyright-holder>
<license>
<ali:license_ref start_date="2026-02-12">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>The incidence of neurodegenerative diseases (NDs) continues to rise worldwide, while conventional pharmacological treatments remain limitations. Consequently, increasing attention has been directed toward to dietary intervention and nutritional supplementation as complementary strategies to prevent these diseases. Ferroptosis (an iron-dependent cell death driven by toxic lipid peroxidation) has become a key therapeutic target within NDs&#x2019; complex pathological landscape. Nuclear factor-erythroid 2-related factor 2 (Nrf2) signaling pathway is the core mechanism of neuron&#x2019;s resistance to ferroptosis, which can regulate the production of the key anti-ferroptosis enzyme glutathione peroxidase 4 (GPX4). Although commonly used culinary spices are well recognized for their flavor and antioxidant effects, their specific functions as natural ferroptosis inhibitors have not been deeply studied. This review systematically evaluates the neuroprotective potential of these dietary components, and introduces in detail how they can reduce iron accumulation, lipid peroxidation, oxidative stress and neuroinflammation by activating Nrf2/GPX4 pathway. By synthesizing the current evidence, we emphasize a prospect: adding bioactive spices into our daily nutrition plan can be a promising, easy-to-obtain and safe method to help us maintain the stability of nervous system and build resistance to NDs.</p>
</abstract>
<kwd-group>
<kwd>culinary spices</kwd>
<kwd>ferroptosis</kwd>
<kwd>glutathione peroxidase 4</kwd>
<kwd>neurodegenerative diseases</kwd>
<kwd>nuclear factor-erythroid 2-related factor 2</kwd>
</kwd-group>
<funding-group>
<funding-statement>The author(s) declared that financial support was received for this work and/or its publication. This work was supported by Natural Science Foundation of Jiangsu province (grant number: BK20230459), Young Elite Scientists Sponsorship Program by Jiangsu Association for Science and Technology (JSAST) (JSTJ-2024-347), Bethune Charitable Foundation: Shining China -Pharmaceutical Research Capacity Building Funding (Z04J2023E095), Nanjing University of Chinese Medicine Scientific Research Cultivation Project for the First-Class Discipline of Chinese Materia Medica (ZYXPY2024-007).</funding-statement>
</funding-group>
<counts>
<fig-count count="2"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="139"/>
<page-count count="11"/>
<word-count count="9816"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Nutrition, Psychology and Brain Health</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec1">
<label>1</label>
<title>Introduction</title>
<p>Neurodegenerative diseases (NDs), including Alzheimer&#x2019;s disease (AD) and Parkinson&#x2019;s disease (PD), amyotrophic lateral sclerosis (ALS) and Huntington&#x2019;s disease (HD), have become more and more serious global health problems, and their characteristics are that the structure and function of neurons will gradually deteriorate (<xref ref-type="bibr" rid="ref1">1</xref>, <xref ref-type="bibr" rid="ref2">2</xref>). Despite decades of research, traditional drug therapy mainly relieves symptoms and cannot stop the disease from getting worse, so now people are turning to early prevention strategies, such as adjusting diet and taking some functional food supplements (<xref ref-type="bibr" rid="ref3 ref4 ref5">3&#x2013;5</xref>). Although the etiology of NDs is complex, new research has found that ferroptosis (a programmed cell death dependent on iron) may be the key pathogenic factor (<xref ref-type="bibr" rid="ref6">6</xref>). Different from apoptosis, ferroptosis is mainly caused by excessive iron and depletion of glutathione, which leads to the accumulation of toxic lipid peroxides (<xref ref-type="bibr" rid="ref7">7</xref>). There are many polyunsaturated fatty acids (PUFAs) in the brain, and it is easy to accumulate iron, so neurons are naturally vulnerable to ferroptosis induced damage (<xref ref-type="bibr" rid="ref8">8</xref>, <xref ref-type="bibr" rid="ref9">9</xref>). Therefore, it is a promising new direction to study how to regulate ferroptosis, which can help to protect nerve health.</p>
<p>The key for cells to fight against ferroptosis is the nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathway, which is the main regulator of cell protection response (<xref ref-type="bibr" rid="ref10">10</xref>, <xref ref-type="bibr" rid="ref11">11</xref>). Under normal circumstances, Nrf2 will be left in the cytoplasm by Kelch-like ECH-associated protein 1 (Keap1) and then decomposed; But under stress, it will run to the nucleus to start the transcription of antioxidant genes (<xref ref-type="bibr" rid="ref12">12</xref>). Most importantly, Nrf2 directly controls the expression of glutathione peroxidase 4 (GPX4) and cystine/glutinate antiporter (System XC-, consists of SLC7A11 and SLC3A2) (<xref ref-type="bibr" rid="ref13">13</xref>, <xref ref-type="bibr" rid="ref14">14</xref>). GPX4 is recognized as the main enzyme checkpoint, which can neutralize toxic lipid peroxides, thus preventing ferroptosis (<xref ref-type="bibr" rid="ref13">13</xref>, <xref ref-type="bibr" rid="ref15">15</xref>). Recent studies have shown that the down-regulation or inactivation of Nrf2/GPX4 axis is a sign of neurodegenerative diseases (<xref ref-type="bibr" rid="ref16">16</xref>, <xref ref-type="bibr" rid="ref17">17</xref>). Therefore, it is a feasible therapeutic strategy to find natural compounds that can activate Nrf2 signal and restore GPX4 activity, which can enhance the ability of neurons to resist the death of ferroptosis (<xref ref-type="bibr" rid="ref17">17</xref>, <xref ref-type="bibr" rid="ref18">18</xref>). Crucially, this strategy has great advantages over simple &#x201C;direct&#x201D; antioxidants (such as Vitamin C or E). Unlike those direct scavengers, which only neutralize ROS in a stoichiometric way and then are quickly consumed, the activation of Nrf2 will trigger the production of some enzymes, which can play a catalytic role. This brings stronger and more lasting antioxidant capacity, so that our neurons can constantly detoxify lipid peroxides without running out as quickly as direct scavengers.</p>
<p>The spices and condiments we usually eat not only make food more delicious, but also have great medicinal value (<xref ref-type="bibr" rid="ref19">19</xref>). Like curcumin in turmeric, allicin in garlic etc., these natural ingredients have been found to protect our neuron system (<xref ref-type="bibr" rid="ref20 ref21 ref22">20&#x2013;22</xref>). A shared feature of these compounds is their ability to interact with Keap1, help Nrf2 to stabilize, and thus start the antioxidant system in the body (<xref ref-type="bibr" rid="ref22 ref23 ref24">22&#x2013;24</xref>). However, how these spices can prevent ferroptosis through Nrf2/GPX4 has not been completely answered. This review is to make it clear how these compounds from food sources fight ferroptosis, and let us understand why eating more spices can help prevent NDs.</p>
</sec>
<sec id="sec2">
<label>2</label>
<title>Major neurodegenerative diseases</title>
<p>Common pathological hallmarks shared by NDs are illustrated in <xref ref-type="fig" rid="fig1">Figure 1</xref>.</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Common pathological mechanisms underlying neurodegenerative diseases.</p>
</caption>
<graphic xlink:href="fnut-13-1779927-g001.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Infographic showing six contributors to neurodegenerative diseases connected to a human brain illustration: GSH depletion, lipid peroxidation, iron accumulation, mitochondrial dysfunction, neuroinflammation, and protein aggregation, each with a representative icon.</alt-text>
</graphic>
</fig>
<sec id="sec3">
<label>2.1</label>
<title>Alzheimer&#x2019;s disease: the amyloid-ferroptosis loop</title>
<p>The AD manifests through amyloid-&#x03B2; (A&#x03B2;) plaque deposits and Tau protein aggregations in the brain, but new research has found that ferroptosis may be the key reason for the early neurodegeneration of AD (<xref ref-type="bibr" rid="ref7">7</xref>, <xref ref-type="bibr" rid="ref25 ref26 ref27">25&#x2013;27</xref>). Redox-active iron, particularly through Fe<sup>3+</sup>/Fe<sup>2+</sup> redox cycling in complexes with amyloid-&#x03B2;, can promote the generation of reactive oxygen species (ROS). This process contributes to oxidative stress, accelerates A&#x03B2; aggregation, and induces neuroinflammatory responses, driving the neurotoxic processes behind AD (<xref ref-type="bibr" rid="ref28">28</xref>, <xref ref-type="bibr" rid="ref29">29</xref>). Specifically, abnormal iron balance accelerates the formation of A&#x03B2; plaques and tau accumulation, exacerbating its toxic effects and promoting the development of AD (<xref ref-type="bibr" rid="ref30">30</xref>). There is a special &#x201C;Amyloid-Ferroptosis Loop&#x201D; here: iron accumulation will promote the aggregation of A&#x03B2;, and these A&#x03B2; clumps will drill into the neuron membrane, producing a large number of lipid ROS, which will eventually lead to ferroptosis (<xref ref-type="bibr" rid="ref31 ref32 ref33">31&#x2013;33</xref>). In addition, the study also found that the deletion of GPX4 in the forebrain neurons of AD model exhibited neurodegeneration and behavior dysfunction, which made neurons more vulnerable to ferroptosis and oxidative damage (<xref ref-type="bibr" rid="ref34">34</xref>, <xref ref-type="bibr" rid="ref35">35</xref>).</p>
</sec>
<sec id="sec4">
<label>2.2</label>
<title>Parkinson&#x2019;s disease: dopamine oxidation and nigral iron overload</title>
<p>The progress of PD is mainly due to the decrease of dopamine-producing neurons in a place called substantia nigra in the brain, the abnormal accumulation of &#x03B1;-synuclein (&#x03B1;-syn) protein, and the persistent inflammation of the nervous system. These fundamental pathological changes are all due to the fact that the redox balance in our body is broken, which leads to oxidative damage (<xref ref-type="bibr" rid="ref36">36</xref>, <xref ref-type="bibr" rid="ref37">37</xref>). This disease is also related to too much iron in the body and the oxidation and destruction of lipid. Our brain is particularly vulnerable to this kind of injury, because it has a high iron content and oxidation by-products produced by dopamine metabolism (<xref ref-type="bibr" rid="ref38">38</xref>). Studies have shown that the decrease of dopaminergic neurons is caused by ferroptosis (<xref ref-type="bibr" rid="ref39">39</xref>).</p>
<p>Dopaminergic neurons are the core factory to produce dopamine, which is an unstable neurotransmitter and may induce oxidative toxicity in iron-rich substantia nigra. Unstable iron will turn dopamine into DAquinone (DAQ), which lacks electrons. Then, DAQ will form strong chemical bonds with those groups that like to donate electrons, such as those thiol groups found in hemipurine amino acids (<xref ref-type="bibr" rid="ref40">40</xref>, <xref ref-type="bibr" rid="ref41">41</xref>). GPX4 is highly expressed in the brain, and some studies suggest that it may be a potential target of DAQ modification (<xref ref-type="bibr" rid="ref41">41</xref>). In PD, downregulated System Xc- reduces cystine uptake, leading to the decrease of Glutathione (GSH), which is one of the earliest biochemical changes, directly affects the activity of GPX4 (<xref ref-type="bibr" rid="ref14">14</xref>). If the work of GPX4 is suppressed, lipid peroxides in cells will accumulate uncontrollably. Too many of these things will destroy the cell membrane, and then start the process of cells death (<xref ref-type="bibr" rid="ref42">42</xref>, <xref ref-type="bibr" rid="ref43">43</xref>).</p>
</sec>
<sec id="sec5">
<label>2.3</label>
<title>Amyotrophic lateral sclerosis and Huntington&#x2019;s disease</title>
<p>Although the symptoms of ALS and HD are very different, they both have a common problem at the molecular level, that is, mitochondrial dysfunction and lipid peroxidation (<xref ref-type="bibr" rid="ref12">12</xref>, <xref ref-type="bibr" rid="ref44 ref45 ref46 ref47">44&#x2013;47</xref>). In ALS, In ALS, Nrf2 cannot up-regulate System Xc-, which will lead to GSH deficiency. This will make GPX4 enzyme &#x201C;hungry&#x201D; and make it unable to neutralize lipid peroxidation caused by iron overload. This series of reactions directly triggered ferroptosis of motor neurons (<xref ref-type="bibr" rid="ref48 ref49 ref50 ref51">48&#x2013;51</xref>). Motor neurons are particularly sensitive to GPX4. When GPX4 does not work, it will cause nerve degeneration quickly.</p>
<p>The HD is a nervous system disease inherited by genes, which will make the nerve cells deteriorate (<xref ref-type="bibr" rid="ref52">52</xref>). This disease arises from a genetic defect involving an abnormal expansion of CAG repeats within the relevant gene, which produce a harmful mutant huntingtin protein (mtHtt) (<xref ref-type="bibr" rid="ref53">53</xref>, <xref ref-type="bibr" rid="ref54">54</xref>). Accumulating evidence suggests that HD progression involves a self-reinforcing pathological, in which oxidative stress, mitochondrial dysfunction, iron accumulation, lipid peroxidation, and glutathione (GSH) depletion interact and exacerbate one another, thereby contributing to progressive neuronal damage (<xref ref-type="bibr" rid="ref55">55</xref>). The mutated huntingtin protein will disturb the Nrf2 signaling pathway, leading to the accumulation of toxic lipids (<xref ref-type="bibr" rid="ref56">56</xref>). All these strongly indicate that ferroptosis is the main way of brain cell death when getting this disease. It is important that there is a defense mechanism centered on Nrf2 in our cells that can play a protective role. It can help to clear toxic mtHtt protein, reduce harmful brain inflammation, and restore the balance between oxidation and antioxidation in the body (<xref ref-type="bibr" rid="ref57">57</xref>). Furthermore, Nrf2 has been shown to have anti-inflammatory effects and to regulate mitochondrial function and production (<xref ref-type="bibr" rid="ref51">51</xref>, <xref ref-type="bibr" rid="ref58">58</xref>, <xref ref-type="bibr" rid="ref59">59</xref>). Mitochondrial dysfunction and neuroinflammation are characteristic of many neurodegenerative diseases such as ALS and HD, thus Nrf2 has become a promising therapeutic target (<xref ref-type="bibr" rid="ref60">60</xref>).</p>
</sec>
</sec>
<sec id="sec6">
<label>3</label>
<title>Molecular interplay between ferroptosis and the Nrf2 signaling pathway in NDs</title>
<sec id="sec7">
<label>3.1</label>
<title>The core machinery of ferroptosis</title>
<p>Ferroptosis is a recently characterized, complex form of regulated cell death that is different from what we know about apoptosis, necrosis and autophagy (<xref ref-type="bibr" rid="ref61">61</xref>). It is characterized by iron-dependent lipid peroxidation resulting from iron accumulation and the failure of cellular antioxidant systems (<xref ref-type="bibr" rid="ref62">62</xref>). Nerve cells are particularly prone to ferroptosis because of their special cell membrane composition and energy requirements (<xref ref-type="bibr" rid="ref63">63</xref>). There are many PUFAs on the membrane of nerve cells, which are most prone to lipid peroxidation (<xref ref-type="bibr" rid="ref64 ref65 ref66">64&#x2013;66</xref>). The specific enzymes are responsible for loading these fatty acids into phospholipids on the membrane, thus making the cell membrane sensitive to ferroptosis. While iron is indispensable for normal neuronal function, dysregulated iron homeostasis can lead to its accumulation in the brain. Excessive iron in the body is related to the development of some neurodegenerative diseases, such as AD and PD (<xref ref-type="bibr" rid="ref63">63</xref>, <xref ref-type="bibr" rid="ref67">67</xref>). If there is too much iron in cells, Fenton reaction will happen. This is a catalytic process without the help of enzymes, and iron will react with hydrogen peroxide to produce ROS, particularly the highly active hydroxyl radical (<xref ref-type="bibr" rid="ref68">68</xref>). These free radicals will attack the bis-allylic carbon atoms in PUFAs molecules on the cell membrane, and then start a self-sustaining chain reaction called lipid peroxidation. This reaction will produce toxic lipid hydroperoxides, uncontrolled accumulation of lipid hydroperoxides destroy the structure of cell membrane and mitochondrial membrane, make pores appear on the membrane, and the ions will lose balance, and ultimately triggers cell death (<xref ref-type="bibr" rid="ref69">69</xref>).</p>
</sec>
<sec id="sec8">
<label>3.2</label>
<title>System Xc- and GPX4: the primary defense checkpoints</title>
<p>Cells have to work normally by System Xc-/GSH/GPX4 axis, which is the most important anti-oxidation defense line in our central nervous system, to resist a severe destructive process called ferroptosis (<xref ref-type="bibr" rid="ref70">70</xref>, <xref ref-type="bibr" rid="ref71">71</xref>). System Xc- is an amino acid porter which is composed of two different parts and stays on the cell membrane. System Xc- consists of SLC7A11, the substrate-specific light chain, and SLC3A2, a heavy chain subunit essential for transporter stability and membrane trafficking. It functions as a cystine&#x2013;glutamate antiporter, importing cystine while exporting glutamate (<xref ref-type="bibr" rid="ref72">72</xref>). After being brought in, cystine will soon become cysteine, and then under the action of two enzymes, Glutamate-cysteine Ligase and glutathione synthetase, Cysteine will become the key material for manufacturing GSH. GSH itself is a very important helper of &#x201C;donating electrons,&#x201D; which is specially used to help GPX4. GPX4 is a special selenium-containing protein, which is different from other similar enzymes, and can directly turn those complex lipid peroxides in our biofilm into non-toxic lipid alcohols. The working efficiency of GPX4 depends entirely on whether there is selenium cysteine on its active site and whether there is enough GSH in the cell. When suffering from NDs, excessive extracellular glutamate will cause excitotoxicity, which will also competitively inhibit System Xc-, thus depleting GSH in neurons, this will reduce the function of GPX4, destroy the redox balance of our cells, lead to the accumulation of iron-dependent lipid peroxides, and finally promote the cell death, making cells very fragile and prone to ferroptosis (<xref ref-type="bibr" rid="ref73">73</xref>, <xref ref-type="bibr" rid="ref74">74</xref>).</p>
</sec>
<sec id="sec9">
<label>3.3</label>
<title>The Nrf2 signaling pathway as a negative regulator of ferroptosis</title>
<p>The antioxidant defense system in cells is mainly regulated by Nrf2, which acts as a master switch to determine whether cells can survive (<xref ref-type="bibr" rid="ref50">50</xref>). Under normal circumstances, Nrf2 will be trapped in the cytoplasm by Keap1 and will be continuously decomposed. But Keap1 is actually a pressure sensor. When cells are exposed to oxidative stress or positively charged compounds, such as the active ingredient in spices, the specific cysteine residues on Keap1 will change. At this time, Nrf2 is released and can run into the nucleus (<xref ref-type="bibr" rid="ref75">75</xref>, <xref ref-type="bibr" rid="ref76">76</xref>). Crucially, the relationship between Nrf2 and GPX4 directly regulates gene expression: the promoter region of GPX4 gene has antioxidant response elements (ARES). As soon as Nrf2 enters the nucleus, it will stick to these ARE sequences accurately, and directly let GPX4 start transcription and synthesis of protein (<xref ref-type="bibr" rid="ref77">77</xref>, <xref ref-type="bibr" rid="ref78">78</xref>). In this way, the level of GPX4 is increased, and neurons can use it to destroy those toxic lipid peroxides. At the same time, Nrf2 will also increase the expression of SLC7A11, so that it can absorb more cystine to synthesize glutathione, and provide GPX4 with the helper it needs (<xref ref-type="bibr" rid="ref78">78</xref>, <xref ref-type="bibr" rid="ref79">79</xref>). In addition, Nrf2 can also protect iron by increasing iron death controller ferritin heavy chain 1(FTH1), which is the main iron storage molecule in cells. Ferritin&#x2019;s main function is to store iron, so that it can be dissolved without harming cells. If something goes wrong with ferritin protein, it may cause various neurodegenerative diseases (<xref ref-type="bibr" rid="ref80">80</xref>, <xref ref-type="bibr" rid="ref81">81</xref>). In conclusion, activating the Nrf2 pathway is like building a comprehensive shield, which directly strengthens the defense capability of GPX4 on the one hand, and maintains the iron balance on the other hand, thus effectively stopping the ferroptosis process. The molecular interplay between ferroptosis and the Nrf2/GPX4 antioxidant defense axis is shown in <xref ref-type="fig" rid="fig2">Figure 2</xref>.</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p>The molecular interplay between ferroptosis and the Nrf2/GPX4 antioxidant defense axis.</p>
</caption>
<graphic xlink:href="fnut-13-1779927-g002.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Diagram comparing ferroptosis and Nrf2/GPX4 defense pathways in cell membranes. Left side shows iron and peroxide causing membrane damage in neurodegenerative diseases, while right side depicts antioxidant defense via system Xc-, GPX4, and Nrf2 nuclear signaling.</alt-text>
</graphic>
</fig>
</sec>
</sec>
<sec id="sec10">
<label>4</label>
<title>Nrf2 activators from culinary spices</title>
<sec id="sec11">
<label>4.1</label>
<title>Curcumin: the golden spice of neuroprotection</title>
<p>Curcumin, which is extracted from the rhizome of <italic>Curcuma longa</italic>, it is widely used as a cooking spice to add color and flavor to food. Curcumin is a core ingredient in curry and typically plays a significant role in traditional curry recipes. Curcumin gives curry its distinctive golden color and offers numerous health benefits. Beyond its role in cooking, it is also a natural compound that scientists are most concerned about when studying the activation and inhibition of ferroptosis by Nrf2 (<xref ref-type="bibr" rid="ref82">82</xref>). There are <italic>&#x03B1;</italic>, &#x03B2;-unsaturated carbonyl groups in its structure, which can act as Michael receptors and react with Cys151 on Keap1 protein (<xref ref-type="bibr" rid="ref83">83</xref>). This reaction will change the shape of Keap1, thus releasing Nrf2, which can enter the nucleus and start some genes related to antioxidation (<xref ref-type="bibr" rid="ref82">82</xref>). In many experimental models of neurodegenerative diseases such as PD, the use of curcumin has been proved to increase the downstream antioxidant gene expression like GPX4 and heme oxygenase 1(HO-1), thus repairing the antioxidant system of GSH and reducing ROS level in cells (<xref ref-type="bibr" rid="ref84 ref85 ref86">84&#x2013;86</xref>). By maintaining the activity of GPX4, curcumin can effectively prevent the accumulation of lipid peroxide on the cell membrane of neurons and protect the integrity of mitochondria. In addition, curcumin has strong iron-chelating activity, which can catch the excess unstable iron and reduce the supply of materials for Fenton reaction, so that dopaminergic neurons and cortical neurons can be protected through a double-action mechanism to prevent them from dying because of ferroptosis (<xref ref-type="bibr" rid="ref87 ref88 ref89">87&#x2013;89</xref>).</p>
</sec>
<sec id="sec12">
<label>4.2</label>
<title>Organosulfur compounds from garlic and onions</title>
<p>Onion vegetables that are often used as spices during cooking, especially garlic (<italic>Allium sativum</italic>) and onion (<italic>Allium cepa</italic>), are rich in organic sulfur compounds, such as allicin, diallyl sulfide (DAS) and S-allylcysteine (SAC), which have a strong anti-ferroptosis-induced NDs effect (<xref ref-type="bibr" rid="ref90">90</xref>, <xref ref-type="bibr" rid="ref91">91</xref>). Different from direct antioxidants, these sulfur-containing molecules are mainly used as prodrugs and become electrophilic substances that can activate Nrf2 signal pathway after metabolism. When we chop or crush fresh garlic cloves, the enzyme alliinase in the cytoplasm will be activated, and then it will turn alliin into allicin (<xref ref-type="bibr" rid="ref92">92</xref>). Studies have found that allicin can protect our nerves and prevent neurons from being injured by ischemia or brain injury. Moreover, it can make the nerve function better and protect the brain tissue after cerebral hemorrhage (ICH) (<xref ref-type="bibr" rid="ref90">90</xref>, <xref ref-type="bibr" rid="ref93">93</xref>). It is found that arachidonate 15-lipoxygenase (ALOX15) is the key factor in the process of ferroptosis associated with ICH, and alliin can protect nerves by preventing ferroptosis mediated by ALOX15 (<xref ref-type="bibr" rid="ref90">90</xref>). Alliin can inhibit the expression of ALOX15, which can control phospholipid peroxidation and prevent ferroptosis (<xref ref-type="bibr" rid="ref90">90</xref>). In addition, the study found that allicin can alleviate early brain injury and protect the nervous system. It can also reduce cell death by reducing oxidative stress, inhibiting inflammatory reaction, relieving brain swelling and blood&#x2013;brain barrier (BBB) damage. Together, these effects can help to improve the neurological impairment (<xref ref-type="bibr" rid="ref94">94</xref>, <xref ref-type="bibr" rid="ref95">95</xref>). Therefore, allicin can enhance the ability of neurons to scavenge lipid peroxides under oxidative stress.</p>
<p>Moreover, aged garlic extract is an extract from kind of garlic, which contains a large number of water-soluble cysteinyl compounds, leading to its protective effects against oxidative stress and inflammation (<xref ref-type="bibr" rid="ref96">96</xref>, <xref ref-type="bibr" rid="ref97">97</xref>). In addition, it may help Nrf2 enter the nucleus, so that downstream genes (such as glutamate-cysteine ligase modifier GCLM and HO-1) can remain active all the time (<xref ref-type="bibr" rid="ref96">96</xref>). This persistent antioxidant reaction can effectively reduce the toxicity and lipid peroxidation caused by iron, indicating that eating the ingredients in allium vegetables often may be a dietary strategy and can enhance the ability of neurons to resist ferroptosis.</p>
</sec>
<sec id="sec13">
<label>4.3</label>
<title>Cinnamaldehyde: the electrophilic guardian from cinnamon</title>
<p>Cinnamon is a natural spice obtained from the bark of <italic>Cinnamomum</italic> species in the Lauraceae family and widely used in culinary seasonings and traditional medicine (<xref ref-type="bibr" rid="ref98">98</xref>). It contains the main active ingredient cinnamaldehyde, which has antioxidant, anti-inflammatory and metabolic regulating effects (<xref ref-type="bibr" rid="ref99">99</xref>). Cinnamaldehyde is the main component that makes cinnamon have fragrance and taste (<xref ref-type="bibr" rid="ref100">100</xref>, <xref ref-type="bibr" rid="ref101">101</xref>). It is a very active electron acceptor and can directly combine with Nrf2-Keap1 complex. Because it has a lively &#x03B1;, &#x03B2;-unsaturated carbonyl group, cinnamaldehyde will change the cysteine thiol group on Keap1, prevent Nrf2 from being decomposed and make it accumulate (<xref ref-type="bibr" rid="ref102">102</xref>, <xref ref-type="bibr" rid="ref103">103</xref>). This will start a strong antioxidant reaction, which will increase SLC7A11 and GPX4 (<xref ref-type="bibr" rid="ref104">104</xref>). Importantly, recent evidence shows that cinnamaldehyde exerts its anti-ferroptosis effect by lowering the level of Acyl-CoA synthetase long-chain family member 4 (ACSL4) (<xref ref-type="bibr" rid="ref105">105</xref>). Because ACSL4 is responsible for filling the cell membrane with PUFAs (which is the main fuel of ferroptosis), inhibiting it can reduce the available raw materials for lipid peroxidation. By activating Nrf2 defense system and inhibiting pro-oxidase at the same time, cinnamaldehyde can fully protect nerve tissue and avoid ferroptosis.</p>
</sec>
<sec id="sec14">
<label>4.4</label>
<title>Capsaicin and piperine: pungent defenders</title>
<p>Capsaicin is a spicy ingredient in <italic>Capsicum frutescens</italic>, and piperine is an alkaloid in <italic>Piper nigrum</italic> that are widely used as culinary spices to enhance flavor and appetite, which make the tongue feel prickly (<xref ref-type="bibr" rid="ref106">106</xref>). They are also very important in regulating Nrf2/GPX4 axis (<xref ref-type="bibr" rid="ref107">107</xref>, <xref ref-type="bibr" rid="ref108">108</xref>). We usually know that capsaicin is a well-known TRPV1 receptor agonist, which can lower brain oxidative stress and neuroinflammation and help to prevent neuronal death in diseases like PD, AD, cerebral stroke and epilepsy (<xref ref-type="bibr" rid="ref109">109</xref>). A new study found that Capsaicin has its own antioxidant activity through Nrf2 (<xref ref-type="bibr" rid="ref110">110</xref>). When using capsaicin to treat neuronal cells attacked by oxidative stressors, it can increase the accumulation of Nrf2 in the nucleus and increase the levels of HO-1 and GPX4 (<xref ref-type="bibr" rid="ref110 ref111 ref112">110&#x2013;112</xref>).</p>
<p>Similarly, piperine alleviated neurological defect through multiple mechanisms. In a neurotoxicity model, piperine was shown to increase the expression of Nrf2 and HO-1, thus enhancing the whole antioxidant defense system in our body (<xref ref-type="bibr" rid="ref108">108</xref>, <xref ref-type="bibr" rid="ref113">113</xref>, <xref ref-type="bibr" rid="ref114">114</xref>). In addition, piperine can also reduce the production of iNOS, increase the levels of Nrf2 and HO-1, enhance the overall antioxidant capacity, and improve the memory function and myelin repair of hippocampus demyelinating rats (<xref ref-type="bibr" rid="ref115">115</xref>). Interestingly, piperine can also greatly increase the absorption and bioavailability of curcumin, so if these spices are eaten together, it may have a better effect (<xref ref-type="bibr" rid="ref116 ref117 ref118">116&#x2013;118</xref>). By stabilizing Nrf2 and promoting the transcription of anti-ferroptosis related genes, these spicy ingredients help our central nervous system maintain redox homeostasis and prevent iron-dependent cell death.</p>
</sec>
</sec>
<sec sec-type="discussion" id="sec15">
<label>5</label>
<title>Discussion</title>
<p>This review shows a very important new idea: it is a feasible and scientific method to deal with ferroptosis through Nrf2/GPX4, which can help us to fight NDs such as AD, PD, ALS and HD (<xref ref-type="bibr" rid="ref119 ref120 ref121 ref122">119&#x2013;122</xref>). Distinct from general oxidative stress, ferroptosis is a unique modality of iron-dependent regulated cell death driven by lethal lipid peroxidation (<xref ref-type="bibr" rid="ref123">123</xref>). Our analysis points out that the central nervous system is particularly prone to ferroptosis because they contain a lot of PUFAs and high iron flow. Therefore, the decrease of GPX4 observed in diseases such as AD, PD and ALS is not an insignificant phenomenon, but a core cause of nerve cell membrane rupture. Therefore, therapeutic strategies should not be limited to simple free radical scavenging; rather, they should aim to restore the cellular capacity to detoxify lipid peroxides and to regulate labile iron. One of the great things about cooking spices is that they do not focus on one point like many single therapies, but they can play multiple roles at the same time. The &#x201C;structure&#x2013;activity relationship&#x201D; of these food ingredients is very critical. Compounds such as curcumin and cinnamaldehyde have electrophilic &#x03B1;, &#x03B2;-unsaturated carbonyl groups, which enable them to covalently modify the cysteine residue on Keap1 protein like small keys. This interaction at the molecular level is equivalent to &#x201C;unlocking&#x201D; Nrf2, allowing it to run into the nucleus and start the transcription of such good things as System Xc- and GPX4. Importantly, these spices usually have a dual role. Curcumin, for example, is not only an activator of Nrf2, but also can directly chelate iron ions and cut off the Fenton reaction from the source (<xref ref-type="bibr" rid="ref87">87</xref>). This multi-pronged approach can deal with the complex disease conditions than those drugs that only target a single pathway.</p>
<p>Moreover, there may be a synergistic effect between these spices, which means that the whole dietary intervention may protect the brain more than taking supplements alone. The problem of many plant ingredients (especially curcumin) is poor absorption, but adding piperine (from black pepper) can naturally improve the absorption rate, because it can prevent metabolic decomposition and make the ingredients eaten together more effective (<xref ref-type="bibr" rid="ref116">116</xref>). This supports the concept of &#x201C;food as medicine&#x201D;, that is, eating a combined diet of turmeric, garlic, cinnamon and pepper can form a strong defense system and fight against neurodegeneration. These spices can inhibit oxidase and enhance antioxidant defense, help maintain mitochondrial health and prevent catastrophic lipid peroxidation related to NDs.</p>
<p>Generally speaking, it is a great and easy way to regulate Nrf2/GPX4 pathway with spices in the kitchen, which can help us to fight against the neurodegeneration caused by ferroptosis seen in diseases such as AD, PD ALS and HD. However, to turn these molecular mechanisms into effective daily eating habits, we need to use them strategically instead of eating casually. In order to maximize the benefits of protecting the brain, our diet strategy should focus on how to mix spices and eat them for a long time. For example, it is a big problem that curcumin is not easily absorbed by the body, but as emphasized in this review, eating turmeric (curcumin) and black pepper (piperine) together can make the absorption effect particularly good (<xref ref-type="bibr" rid="ref117">117</xref>, <xref ref-type="bibr" rid="ref118">118</xref>). Therefore, a traditional dish like curry, which is naturally mixed with these spices, is a great example of brain-protecting diet. Similarly, taking garlic and onions as the basic ingredients for cooking every day can ensure that we can continuously obtain the organic sulfur compounds needed to replenish the GSH pool. These habits make spices no longer just condiments, but become a long-term, low-dose &#x201C;health care program&#x201D;, which can enhance the antioxidant protection layer of the brain. The key is to understand the therapeutic window. Because severe NDs can lead to irreversible neuronal loss, even if Nrf2 is activated, it cannot be recovered, so these dietary strategies should be mainly used as preventive measures or for prodromal stages (<xref ref-type="bibr" rid="ref124">124</xref>, <xref ref-type="bibr" rid="ref125">125</xref>). Their value lies in delaying the onset and deterioration of the disease, rather than acting as a cure for advanced atrophy.</p>
<p>However, in order to bridge the gap between molecular mechanisms and dietary practice, we have to consider the actual situation when cooking, especially the thermal stability and food matrix effect. First of all, cooking temperature is critical to bioactivity. Alkaloids such as capsaicin is relatively heat-stable, but sulfur-containing compound in garlic are heat-sensitive (<xref ref-type="bibr" rid="ref126">126</xref>, <xref ref-type="bibr" rid="ref127">127</xref>). Allicin is an activator of Nrf2, which will rapidly degraded upon exposure to high temperatures (<xref ref-type="bibr" rid="ref126">126</xref>). Therefore, it is suggested that crushing garlic and allowing it to stand before adding it at the final stage of cooking, so as to keep its biological activity. Conversely, for lipophilic ingredients like curcumin, the cooking process plays a good role through the &#x201C;food matrix effect&#x201D;. Eating these spices together with fatty things (such as olive oil or milk) can not only facilitate their extraction during heating, but also stimulate bile secretion and form micelle, these processes markedly improve intestinal uptake compared with administration in aqueous forms (<xref ref-type="bibr" rid="ref128">128</xref>, <xref ref-type="bibr" rid="ref129">129</xref>). Therefore, traditional cooking methods-such as using tempering spices in oil or pairing them with dietary fats actually a good method with scientific basis, which can maximize the stability and bioavailability of these neuroprotective agents.</p>
<p>Although promising, we still have to solve several problems to improve this method. Bioavailability is still the main bottleneck. Oral curcumin is not easily absorbed by our body, and it is metabolized quickly, so its bioavailability is particularly low, leading to its excretion rather than entry into systemic circulation (<xref ref-type="bibr" rid="ref130">130</xref>). Future research should explore more advanced delivery systems, such as nano-formulations or lipid-based carriers, to improve the stability and brain absorption of active ingredients such as curcumin and allicin (<xref ref-type="bibr" rid="ref131 ref132 ref133">131&#x2013;133</xref>). In addition, dose standardization is also critical. Although epidemiological studies show that regular consumption is beneficial, we still lack accurate clinical guidelines to explain how much &#x201C;effective dose&#x201D; is needed to inhibit ferroptosis without causing gastrointestinal discomfort. Besides bioavailability and dosage, special attention should be paid to the safety of activating Nrf2. Although Nrf2 is widely recognized for its neuroprotective properties, it is often described as a &#x2018;double-edged sword,&#x2019; as persistent activation that arising from genetic alterations can protect cancer cells from chemotherapy and facilitate tumor growth (<xref ref-type="bibr" rid="ref134">134</xref>). However, it is important that the activation of Nrf2 caused by spices is usually transient and reversible, depending on the metabolism of those active ingredients, which is completely different from the continuous and dysregulated activation in cancer (<xref ref-type="bibr" rid="ref135">135</xref>, <xref ref-type="bibr" rid="ref136">136</xref>). Nonetheless, prudence is warranted when high-dose supplementation is contemplated, particularly in older individuals who may have undiagnosed or active malignancies. In addition, patients with neurodegenerative diseases are commonly exposed to multiple medications, making potential herb&#x2013;drug interactions an important practical concern. Examples include the anticoagulant effect of garlic or the inhibition of metabolic enzymes (such as CYP450) by piperine and curcumin should be considered to avoid adverse effects (<xref ref-type="bibr" rid="ref137 ref138 ref139">137&#x2013;139</xref>). Finally, strict clinical trials must be conducted to measure specific ferroptosis biomarkers in patients to confirm whether these dietary interventions can really slow down the progress of neurodegenerative diseases in clinical settings. In the final analysis, although spices cannot replace drug therapy, it can be a safe, cost-effective and multi-target adjuvant therapy by integrating them into daily diet. By creating a body environment that can resist ferroptosis through nutrition, we may be able to delay the occurrence of neurodegeneration and improve the quality of life of the elderly.</p>
</sec>
<sec sec-type="conclusions" id="sec16">
<label>6</label>
<title>Conclusion</title>
<p>In conclusion, ferroptosis is the key pathogenic link of NDs, which is mainly driven by iron overload and lipid peroxidation. This review emphasizes the therapeutic potential of kitchen spices-especially curcumin, allicin, cinnamaldehyde, capsaicin and piperine-as powerful multi-target ferroptosis inhibitors. From the mechanism point of view, these bioactive compounds can provide neuroprotection by activating the classical Nrf2/GPX4 defense axis and isolating unstable iron. In addition, dietary strategies such as combining curcumin with piperine show how the synergistic combination can effectively overcome the obstacle of bioavailability. Although the future transformation research needs to solve the problems of delivery optimization and dosage standardization, integrating these spices into daily diet provides a promising, safe and economical &#x201C;food-as-medicine&#x201D; strategy for enhancing the resilience of neurons against neurodegeneration.</p>
</sec>
</body>
<back>
<sec sec-type="author-contributions" id="sec17">
<title>Author contributions</title>
<p>WH: Conceptualization, Methodology, Writing &#x2013; original draft. YQ: Data curation, Formal analysis, Funding acquisition, Writing &#x2013; review &#x0026; editing. JL: Funding acquisition, Resources, Supervision, Writing &#x2013; review &#x0026; editing.</p>
</sec>
<sec sec-type="COI-statement" id="sec18">
<title>Conflict of interest</title>
<p>The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="sec19">
<title>Generative AI statement</title>
<p>The author(s) declared that Generative AI was not used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec sec-type="disclaimer" id="sec20">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Q</given-names></name> <name><surname>Liu</surname><given-names>J</given-names></name> <name><surname>Huang</surname><given-names>S</given-names></name> <name><surname>Wang</surname><given-names>XY</given-names></name> <name><surname>Chen</surname><given-names>X</given-names></name> <name><surname>Liu</surname><given-names>GH</given-names></name> <etal/></person-group>. <article-title>Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances</article-title>. <source>Signal Transduct Target Ther</source>. (<year>2025</year>) <volume>10</volume>:<fpage>76</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41392-025-02145-7</pub-id>, <pub-id pub-id-type="pmid">40059211</pub-id></mixed-citation></ref>
<ref id="ref2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agnello</surname><given-names>L</given-names></name> <name><surname>Ciaccio</surname><given-names>M</given-names></name></person-group>. <article-title>Neurodegenerative diseases: from molecular basis to therapy</article-title>. <source>Int J Mol Sci</source>. (<year>2022</year>) <volume>23</volume>:<fpage>12854</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms232112854</pub-id>, <pub-id pub-id-type="pmid">36361643</pub-id></mixed-citation></ref>
<ref id="ref3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Renzo</surname><given-names>L</given-names></name> <name><surname>Gualtieri</surname><given-names>P</given-names></name> <name><surname>De Lorenzo</surname><given-names>A</given-names></name></person-group>. <article-title>Diet, nutrition and chronic degenerative diseases</article-title>. <source>Nutrients</source>. (<year>2021</year>) <volume>13</volume>:<fpage>1372</fpage>. doi: <pub-id pub-id-type="doi">10.3390/nu13041372</pub-id>, <pub-id pub-id-type="pmid">33923865</pub-id></mixed-citation></ref>
<ref id="ref4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stefaniak</surname><given-names>O</given-names></name> <name><surname>Dobrzy&#x0144;ska</surname><given-names>M</given-names></name> <name><surname>Drzyma&#x0142;a-Czy&#x017C;</surname><given-names>S</given-names></name> <name><surname>Przys&#x0142;awski</surname><given-names>J</given-names></name></person-group>. <article-title>Diet in the prevention of Alzheimer's disease: current knowledge and future research requirements</article-title>. <source>Nutrients</source>. (<year>2022</year>) <volume>14</volume>:<fpage>4564</fpage>. doi: <pub-id pub-id-type="doi">10.3390/nu14214564</pub-id>, <pub-id pub-id-type="pmid">36364826</pub-id></mixed-citation></ref>
<ref id="ref5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dy&#x0144;ka</surname><given-names>D</given-names></name> <name><surname>Kowalcze</surname><given-names>K</given-names></name> <name><surname>Paziewska</surname><given-names>A</given-names></name></person-group>. <article-title>The role of ketogenic diet in the treatment of neurological diseases</article-title>. <source>Nutrients</source>. (<year>2022</year>) <volume>14</volume>:<fpage>5003</fpage>. doi: <pub-id pub-id-type="doi">10.3390/nu14235003</pub-id>, <pub-id pub-id-type="pmid">36501033</pub-id></mixed-citation></ref>
<ref id="ref6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>TPM</given-names></name> <name><surname>Alves</surname><given-names>F</given-names></name> <name><surname>Lane</surname><given-names>DJR</given-names></name> <name><surname>Bush</surname><given-names>AI</given-names></name> <name><surname>Ayton</surname><given-names>S</given-names></name></person-group>. <article-title>Triggering ferroptosis in neurodegenerative diseases</article-title>. <source>Trends Neurosci</source>. (<year>2025</year>) <volume>48</volume>:<fpage>750</fpage>&#x2013;<lpage>65</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.tins.2025.06.008</pub-id>, <pub-id pub-id-type="pmid">40695640</pub-id></mixed-citation></ref>
<ref id="ref7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>HF</given-names></name> <name><surname>Zou</surname><given-names>T</given-names></name> <name><surname>Tuo</surname><given-names>QZ</given-names></name> <name><surname>Xu</surname><given-names>S</given-names></name> <name><surname>Li</surname><given-names>H</given-names></name> <name><surname>Belaidi</surname><given-names>AA</given-names></name> <etal/></person-group>. <article-title>Ferroptosis: mechanisms and links with diseases</article-title>. <source>Signal Transduct Target Ther</source>. (<year>2021</year>) <volume>6</volume>:<fpage>49</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41392-020-00428-9</pub-id>, <pub-id pub-id-type="pmid">33536413</pub-id></mixed-citation></ref>
<ref id="ref8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacquemyn</surname><given-names>J</given-names></name> <name><surname>Ralhan</surname><given-names>I</given-names></name> <name><surname>Ioannou</surname><given-names>MS</given-names></name></person-group>. <article-title>Driving factors of neuronal ferroptosis</article-title>. <source>Trends Cell Biol</source>. (<year>2024</year>) <volume>34</volume>:<fpage>535</fpage>&#x2013;<lpage>46</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.tcb.2024.01.010</pub-id>, <pub-id pub-id-type="pmid">38395733</pub-id></mixed-citation></ref>
<ref id="ref9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>Y</given-names></name> <name><surname>Zhang</surname><given-names>Y</given-names></name> <name><surname>Zhao</surname><given-names>X</given-names></name> <name><surname>Shao</surname><given-names>L</given-names></name> <name><surname>Liu</surname><given-names>G</given-names></name> <name><surname>Sun</surname><given-names>C</given-names></name> <etal/></person-group>. <article-title>ACSL4 exacerbates ischemic stroke by promoting ferroptosis-induced brain injury and neuroinflammation</article-title>. <source>Brain Behav Immun</source>. (<year>2021</year>) <volume>93</volume>:<fpage>312</fpage>&#x2013;<lpage>21</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbi.2021.01.003</pub-id>, <pub-id pub-id-type="pmid">33444733</pub-id></mixed-citation></ref>
<ref id="ref10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>D</given-names></name> <name><surname>Chen</surname><given-names>X</given-names></name> <name><surname>Kang</surname><given-names>R</given-names></name> <name><surname>Kroemer</surname><given-names>G</given-names></name></person-group>. <article-title>Ferroptosis: molecular mechanisms and health implications</article-title>. <source>Cell Res</source>. (<year>2021</year>) <volume>31</volume>:<fpage>107</fpage>&#x2013;<lpage>25</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41422-020-00441-1</pub-id>, <pub-id pub-id-type="pmid">33268902</pub-id></mixed-citation></ref>
<ref id="ref11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>X</given-names></name> <name><surname>Wang</surname><given-names>Y</given-names></name> <name><surname>Zhu</surname><given-names>X</given-names></name> <name><surname>Chen</surname><given-names>Y</given-names></name> <name><surname>Xu</surname><given-names>B</given-names></name> <name><surname>Bai</surname><given-names>X</given-names></name> <etal/></person-group>. <article-title>MCL attenuates atherosclerosis by suppressing macrophage ferroptosis via targeting KEAP1/NRF2 interaction</article-title>. <source>Redox Biol</source>. (<year>2024</year>) <volume>69</volume>:<fpage>102987</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.redox.2023.102987</pub-id></mixed-citation></ref>
<ref id="ref12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiang</surname><given-names>Y</given-names></name> <name><surname>Song</surname><given-names>X</given-names></name> <name><surname>Long</surname><given-names>D</given-names></name></person-group>. <article-title>Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases</article-title>. <source>Arch Toxicol</source>. (<year>2024</year>) <volume>98</volume>:<fpage>579</fpage>&#x2013;<lpage>615</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00204-023-03660-8</pub-id>, <pub-id pub-id-type="pmid">38265475</pub-id></mixed-citation></ref>
<ref id="ref13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>M</given-names></name> <name><surname>Zhang</surname><given-names>D</given-names></name> <name><surname>Yan</surname><given-names>J</given-names></name></person-group>. <article-title>Targeting ferroptosis using Chinese herbal compounds to treat respiratory diseases</article-title>. <source>Phytomedicine</source>. (<year>2024</year>) <volume>130</volume>:<fpage>155738</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.phymed.2024.155738</pub-id>, <pub-id pub-id-type="pmid">38824825</pub-id></mixed-citation></ref>
<ref id="ref14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>Q</given-names></name> <name><surname>Yang</surname><given-names>J</given-names></name> <name><surname>Pan</surname><given-names>Z</given-names></name> <name><surname>Zhang</surname><given-names>G</given-names></name> <name><surname>Chen</surname><given-names>B</given-names></name> <name><surname>Li</surname><given-names>S</given-names></name> <etal/></person-group>. <article-title>Biochanin a protects against iron overload associated knee osteoarthritis via regulating iron levels and NRF2/system xc-/GPX4 axis</article-title>. <source>Biomed Pharmacother</source>. (<year>2023</year>) <volume>157</volume>:<fpage>113915</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.biopha.2022.113915</pub-id>, <pub-id pub-id-type="pmid">36379122</pub-id></mixed-citation></ref>
<ref id="ref15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>C</given-names></name> <name><surname>Sun</surname><given-names>S</given-names></name> <name><surname>Johnson</surname><given-names>T</given-names></name> <name><surname>Qi</surname><given-names>R</given-names></name> <name><surname>Zhang</surname><given-names>S</given-names></name> <name><surname>Zhang</surname><given-names>J</given-names></name> <etal/></person-group>. <article-title>The glutathione peroxidase Gpx4 prevents lipid peroxidation and ferroptosis to sustain Treg cell activation and suppression of antitumor immunity</article-title>. <source>Cell Rep</source>. (<year>2021</year>) <volume>35</volume>:<fpage>109235</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.celrep.2021.109235</pub-id>, <pub-id pub-id-type="pmid">34133924</pub-id></mixed-citation></ref>
<ref id="ref16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>S</given-names></name> <name><surname>Wang</surname><given-names>L</given-names></name> <name><surname>Zeng</surname><given-names>Y</given-names></name> <name><surname>Wang</surname><given-names>Y</given-names></name> <name><surname>Pei</surname><given-names>T</given-names></name> <name><surname>Xie</surname><given-names>Z</given-names></name> <etal/></person-group>. <article-title>Salidroside alleviates cognitive impairment by inhibiting ferroptosis via activation of the Nrf2/GPX4 axis in SAMP8 mice</article-title>. <source>Phytomedicine</source>. (<year>2023</year>) <volume>114</volume>:<fpage>154762</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.phymed.2023.154762</pub-id>, <pub-id pub-id-type="pmid">36965372</pub-id></mixed-citation></ref>
<ref id="ref17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C</given-names></name> <name><surname>Chen</surname><given-names>S</given-names></name> <name><surname>Guo</surname><given-names>H</given-names></name> <name><surname>Jiang</surname><given-names>H</given-names></name> <name><surname>Liu</surname><given-names>H</given-names></name> <name><surname>Fu</surname><given-names>H</given-names></name> <etal/></person-group>. <article-title>Forsythoside a mitigates Alzheimer's-like pathology by inhibiting Ferroptosis-mediated Neuroinflammation via Nrf2/GPX4 Axis activation</article-title>. <source>Int J Biol Sci</source>. (<year>2022</year>) <volume>18</volume>:<fpage>2075</fpage>&#x2013;<lpage>90</lpage>. doi: <pub-id pub-id-type="doi">10.7150/ijbs.69714</pub-id>, <pub-id pub-id-type="pmid">35342364</pub-id></mixed-citation></ref>
<ref id="ref18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lane</surname><given-names>DJR</given-names></name> <name><surname>Metselaar</surname><given-names>B</given-names></name> <name><surname>Greenough</surname><given-names>M</given-names></name> <name><surname>Bush</surname><given-names>AI</given-names></name> <name><surname>Ayton</surname><given-names>SJ</given-names></name></person-group>. <article-title>Ferroptosis and NRF2: an emerging battlefield in the neurodegeneration of Alzheimer's disease</article-title>. <source>Essays Biochem</source>. (<year>2021</year>) <volume>65</volume>:<fpage>925</fpage>&#x2013;<lpage>40</lpage>. doi: <pub-id pub-id-type="doi">10.1042/EBC20210017</pub-id>, <pub-id pub-id-type="pmid">34623415</pub-id></mixed-citation></ref>
<ref id="ref19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>J</given-names></name> <name><surname>Huang</surname><given-names>T</given-names></name> <name><surname>Li</surname><given-names>J</given-names></name></person-group>. <article-title>Regulation mechanism and potential value of active substances in spices in alcohol-liver-intestine axis health</article-title>. <source>Int J Mol Sci</source>. (<year>2024</year>) <volume>25</volume>:<fpage>3728</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms25073728</pub-id>, <pub-id pub-id-type="pmid">38612538</pub-id></mixed-citation></ref>
<ref id="ref20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>X</given-names></name> <name><surname>Zhang</surname><given-names>X</given-names></name> <name><surname>Li</surname><given-names>R</given-names></name> <name><surname>Yang</surname><given-names>X</given-names></name> <name><surname>Fu</surname><given-names>P</given-names></name> <name><surname>Feng</surname><given-names>R</given-names></name> <etal/></person-group>. <article-title>Platelet membrane-coated curcumin-PLGA nanoparticles promote astrocyte-neuron transdifferentiation for intracerebral hemorrhage treatment</article-title>. <source>Small</source>. (<year>2024</year>) <volume>20</volume>:<fpage>e2311128</fpage>. doi: <pub-id pub-id-type="doi">10.1002/smll.202311128</pub-id>, <pub-id pub-id-type="pmid">38888124</pub-id></mixed-citation></ref>
<ref id="ref21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>Y</given-names></name> <name><surname>Gu</surname><given-names>W</given-names></name> <name><surname>Wu</surname><given-names>X</given-names></name> <name><surname>Tian</surname><given-names>W</given-names></name> <name><surname>Mu</surname><given-names>Z</given-names></name> <name><surname>Ye</surname><given-names>Y</given-names></name> <etal/></person-group>. <article-title>Allicin alleviates traumatic brain injury-induced neuroinflammation by enhancing PKC-&#x03B4;-mediated mitophagy</article-title>. <source>Phytomedicine</source>. (<year>2025</year>) <volume>139</volume>:<fpage>156500</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.phymed.2025.156500</pub-id>, <pub-id pub-id-type="pmid">39986225</pub-id></mixed-citation></ref>
<ref id="ref22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edres</surname><given-names>HA</given-names></name> <name><surname>Taha</surname><given-names>NM</given-names></name> <name><surname>Lebda</surname><given-names>MA</given-names></name> <name><surname>Elfeky</surname><given-names>MS</given-names></name></person-group>. <article-title>The potential neuroprotective effect of allicin and melatonin in acrylamide-induced brain damage in rats</article-title>. <source>Environ Sci Pollut Res Int</source>. (<year>2021</year>) <volume>28</volume>:<fpage>58768</fpage>&#x2013;<lpage>80</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11356-021-14800-x</pub-id>, <pub-id pub-id-type="pmid">34120280</pub-id></mixed-citation></ref>
<ref id="ref23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J</given-names></name> <name><surname>Song</surname><given-names>X</given-names></name> <name><surname>Feng</surname><given-names>Y</given-names></name> <name><surname>Liu</surname><given-names>N</given-names></name> <name><surname>Fu</surname><given-names>Z</given-names></name> <name><surname>Wu</surname><given-names>J</given-names></name> <etal/></person-group>. <article-title>Natural ingredients-derived antioxidants attenuate H(2)O(2)-induced oxidative stress and have chondroprotective effects on human osteoarthritic chondrocytes via Keap1/Nrf2 pathway</article-title>. <source>Free Radic Biol Med</source>. (<year>2020</year>) <volume>152</volume>:<fpage>854</fpage>&#x2013;<lpage>64</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2020.01.185</pub-id>, <pub-id pub-id-type="pmid">32014502</pub-id></mixed-citation></ref>
<ref id="ref24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>JW</given-names></name> <name><surname>Chun</surname><given-names>KS</given-names></name> <name><surname>Kim</surname><given-names>DH</given-names></name> <name><surname>Kim</surname><given-names>SJ</given-names></name> <name><surname>Kim</surname><given-names>SH</given-names></name> <name><surname>Cho</surname><given-names>NC</given-names></name> <etal/></person-group>. <article-title>Curcumin induces stabilization of Nrf2 protein through Keap1 cysteine modification</article-title>. <source>Biochem Pharmacol</source>. (<year>2020</year>) <volume>173</volume>:<fpage>113820</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bcp.2020.113820</pub-id>, <pub-id pub-id-type="pmid">31972171</pub-id></mixed-citation></ref>
<ref id="ref25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ballard</surname><given-names>C</given-names></name> <name><surname>Gauthier</surname><given-names>S</given-names></name> <name><surname>Corbett</surname><given-names>A</given-names></name> <name><surname>Brayne</surname><given-names>C</given-names></name> <name><surname>Aarsland</surname><given-names>D</given-names></name> <name><surname>Jones</surname><given-names>E</given-names></name></person-group>. <article-title>Alzheimer's disease</article-title>. <source>Lancet</source>. (<year>2011</year>) <volume>377</volume>:<fpage>1019</fpage>&#x2013;<lpage>31</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0140-6736(10)61349-9</pub-id>, <pub-id pub-id-type="pmid">21371747</pub-id></mixed-citation></ref>
<ref id="ref26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graff-Radford</surname><given-names>J</given-names></name> <name><surname>Yong</surname><given-names>KXX</given-names></name> <name><surname>Apostolova</surname><given-names>LG</given-names></name> <name><surname>Bouwman</surname><given-names>FH</given-names></name> <name><surname>Carrillo</surname><given-names>M</given-names></name> <name><surname>Dickerson</surname><given-names>BC</given-names></name> <etal/></person-group>. <article-title>New insights into atypical Alzheimer's disease in the era of biomarkers</article-title>. <source>Lancet Neurol</source>. (<year>2021</year>) <volume>20</volume>:<fpage>222</fpage>&#x2013;<lpage>34</lpage>. doi: <pub-id pub-id-type="doi">10.1016/s1474-4422(20)30440-3</pub-id>, <pub-id pub-id-type="pmid">33609479</pub-id></mixed-citation></ref>
<ref id="ref27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stockwell</surname><given-names>BR</given-names></name> <name><surname>Friedmann Angeli</surname><given-names>JP</given-names></name> <name><surname>Bayir</surname><given-names>H</given-names></name> <name><surname>Bush</surname><given-names>AI</given-names></name> <name><surname>Conrad</surname><given-names>M</given-names></name> <name><surname>Dixon</surname><given-names>SJ</given-names></name> <etal/></person-group>. <article-title>Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease</article-title>. <source>Cell</source>. (<year>2017</year>) <volume>171</volume>:<fpage>273</fpage>&#x2013;<lpage>85</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2017.09.021</pub-id>, <pub-id pub-id-type="pmid">28985560</pub-id></mixed-citation></ref>
<ref id="ref28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheignon</surname><given-names>C</given-names></name> <name><surname>Tomas</surname><given-names>M</given-names></name> <name><surname>Bonnefont-Rousselot</surname><given-names>D</given-names></name> <name><surname>Faller</surname><given-names>P</given-names></name> <name><surname>Hureau</surname><given-names>C</given-names></name> <name><surname>Collin</surname><given-names>F</given-names></name></person-group>. <article-title>Oxidative stress and the amyloid beta peptide in Alzheimer's disease</article-title>. <source>Redox Biol</source>. (<year>2018</year>) <volume>14</volume>:<fpage>450</fpage>&#x2013;<lpage>64</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.redox.2017.10.014</pub-id>, <pub-id pub-id-type="pmid">29080524</pub-id></mixed-citation></ref>
<ref id="ref29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramesh</surname><given-names>M</given-names></name> <name><surname>Govindaraju</surname><given-names>T</given-names></name></person-group>. <article-title>Multipronged diagnostic and therapeutic strategies for Alzheimer's disease</article-title>. <source>Chem Sci</source>. (<year>2022</year>) <volume>13</volume>:<fpage>13657</fpage>&#x2013;<lpage>89</lpage>. doi: <pub-id pub-id-type="doi">10.1039/d2sc03932j</pub-id>, <pub-id pub-id-type="pmid">36544728</pub-id></mixed-citation></ref>
<ref id="ref30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ward</surname><given-names>RJ</given-names></name> <name><surname>Zucca</surname><given-names>FA</given-names></name> <name><surname>Duyn</surname><given-names>JH</given-names></name> <name><surname>Crichton</surname><given-names>RR</given-names></name> <name><surname>Zecca</surname><given-names>L</given-names></name></person-group>. <article-title>The role of iron in brain ageing and neurodegenerative disorders</article-title>. <source>Lancet Neurol</source>. (<year>2014</year>) <volume>13</volume>:<fpage>1045</fpage>&#x2013;<lpage>60</lpage>. doi: <pub-id pub-id-type="doi">10.1016/s1474-4422(14)70117-6</pub-id>, <pub-id pub-id-type="pmid">25231526</pub-id></mixed-citation></ref>
<ref id="ref31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Majern&#x00ED;kov&#x00E1;</surname><given-names>N</given-names></name> <name><surname>Marmolejo-Garza</surname><given-names>A</given-names></name> <name><surname>Salinas</surname><given-names>CS</given-names></name> <name><surname>Luu</surname><given-names>MDA</given-names></name> <name><surname>Zhang</surname><given-names>Y</given-names></name> <name><surname>Trombetta-Lima</surname><given-names>M</given-names></name> <etal/></person-group>. <article-title>The link between amyloid &#x03B2; and ferroptosis pathway in Alzheimer's disease progression</article-title>. <source>Cell Death Dis</source>. (<year>2024</year>) <volume>15</volume>:<fpage>782</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41419-024-07152-0</pub-id>, <pub-id pub-id-type="pmid">39468028</pub-id></mixed-citation></ref>
<ref id="ref32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Padhi</surname><given-names>D</given-names></name> <name><surname>Baruah</surname><given-names>P</given-names></name> <name><surname>Ramesh</surname><given-names>M</given-names></name> <name><surname>Moorthy</surname><given-names>H</given-names></name> <name><surname>Govindaraju</surname><given-names>T</given-names></name></person-group>. <article-title>Hybrid molecules synergistically mitigate ferroptosis and amyloid-associated toxicities in Alzheimer's disease</article-title>. <source>Redox Biol</source>. (<year>2024</year>) <volume>71</volume>:<fpage>103119</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.redox.2024.103119</pub-id>, <pub-id pub-id-type="pmid">38507972</pub-id></mixed-citation></ref>
<ref id="ref33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Streit</surname><given-names>WJ</given-names></name> <name><surname>Phan</surname><given-names>L</given-names></name> <name><surname>Bechmann</surname><given-names>I</given-names></name></person-group>. <article-title>Ferroptosis and pathogenesis of neuritic plaques in Alzheimer disease</article-title>. <source>Pharmacol Rev</source>. (<year>2025</year>) <volume>77</volume>:<fpage>100005</fpage>. doi: <pub-id pub-id-type="doi">10.1124/pharmrev.123.000823</pub-id>, <pub-id pub-id-type="pmid">39952690</pub-id></mixed-citation></ref>
<ref id="ref34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorenz</surname><given-names>SM</given-names></name> <name><surname>Wahida</surname><given-names>A</given-names></name> <name><surname>Bostock</surname><given-names>MJ</given-names></name> <name><surname>Seibt</surname><given-names>T</given-names></name> <name><surname>Santos Dias Mour&#x00E3;o</surname><given-names>A</given-names></name> <name><surname>Levkina</surname><given-names>A</given-names></name> <etal/></person-group>. <article-title>A fin-loop-like structure in GPX4 underlies neuroprotection from ferroptosis</article-title>. <source>Cell</source>. (<year>2026</year>) <volume>189</volume>:<fpage>287</fpage>&#x2013;<lpage>306.e35</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2025.11.014</pub-id></mixed-citation></ref>
<ref id="ref35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hambright</surname><given-names>WS</given-names></name> <name><surname>Fonseca</surname><given-names>RS</given-names></name> <name><surname>Chen</surname><given-names>L</given-names></name> <name><surname>Na</surname><given-names>R</given-names></name> <name><surname>Ran</surname><given-names>Q</given-names></name></person-group>. <article-title>Ablation of ferroptosis regulator glutathione peroxidase 4 in forebrain neurons promotes cognitive impairment and neurodegeneration</article-title>. <source>Redox Biol</source>. (<year>2017</year>) <volume>12</volume>:<fpage>8</fpage>&#x2013;<lpage>17</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.redox.2017.01.021</pub-id>, <pub-id pub-id-type="pmid">28212525</pub-id></mixed-citation></ref>
<ref id="ref36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>T</given-names></name> <name><surname>Kong</surname><given-names>X</given-names></name> <name><surname>Qiao</surname><given-names>J</given-names></name> <name><surname>Wei</surname><given-names>J</given-names></name></person-group>. <article-title>Decoding Parkinson's disease: the interplay of cell death pathways, oxidative stress, and therapeutic innovations</article-title>. <source>Redox Biol</source>. (<year>2025</year>) <volume>85</volume>:<fpage>103787</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.redox.2025.103787</pub-id>, <pub-id pub-id-type="pmid">40712453</pub-id></mixed-citation></ref>
<ref id="ref37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>J</given-names></name> <name><surname>Lin</surname><given-names>XM</given-names></name> <name><surname>Lu</surname><given-names>DH</given-names></name> <name><surname>Wang</surname><given-names>M</given-names></name> <name><surname>Li</surname><given-names>K</given-names></name> <name><surname>Li</surname><given-names>SR</given-names></name> <etal/></person-group>. <article-title>Midbrain dopamine oxidation links ubiquitination of glutathione peroxidase 4 to ferroptosis of dopaminergic neurons</article-title>. <source>J Clin Invest</source>. (<year>2023</year>) <volume>133</volume>:<fpage>e165228</fpage>. doi: <pub-id pub-id-type="doi">10.1172/JCI165228</pub-id></mixed-citation></ref>
<ref id="ref38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>D</given-names></name> <name><surname>Minikes</surname><given-names>AM</given-names></name> <name><surname>Jiang</surname><given-names>X</given-names></name></person-group>. <article-title>Ferroptosis at the intersection of lipid metabolism and cellular signaling</article-title>. <source>Mol Cell</source>. (<year>2022</year>) <volume>82</volume>:<fpage>2215</fpage>&#x2013;<lpage>27</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.molcel.2022.03.022</pub-id>, <pub-id pub-id-type="pmid">35390277</pub-id></mixed-citation></ref>
<ref id="ref39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>WY</given-names></name> <name><surname>Tyurin</surname><given-names>VA</given-names></name> <name><surname>Mikulska-Ruminska</surname><given-names>K</given-names></name> <name><surname>Shrivastava</surname><given-names>IH</given-names></name> <name><surname>Anthonymuthu</surname><given-names>TS</given-names></name> <name><surname>Zhai</surname><given-names>YJ</given-names></name> <etal/></person-group>. <article-title>Phospholipase iPLA(2)&#x03B2; averts ferroptosis by eliminating a redox lipid death signal</article-title>. <source>Nat Chem Biol</source>. (<year>2021</year>) <volume>17</volume>:<fpage>465</fpage>&#x2013;<lpage>76</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41589-020-00734-x</pub-id>, <pub-id pub-id-type="pmid">33542532</pub-id></mixed-citation></ref>
<ref id="ref40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akagawa</surname><given-names>M</given-names></name> <name><surname>Ishii</surname><given-names>Y</given-names></name> <name><surname>Ishii</surname><given-names>T</given-names></name> <name><surname>Shibata</surname><given-names>T</given-names></name> <name><surname>Yotsu-Yamashita</surname><given-names>M</given-names></name> <name><surname>Suyama</surname><given-names>K</given-names></name> <etal/></person-group>. <article-title>Metal-catalyzed oxidation of protein-bound dopamine</article-title>. <source>Biochemistry</source>. (<year>2006</year>) <volume>45</volume>:<fpage>15120</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1021/bi0614434</pub-id>, <pub-id pub-id-type="pmid">17154550</pub-id></mixed-citation></ref>
<ref id="ref41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hauser</surname><given-names>DN</given-names></name> <name><surname>Dukes</surname><given-names>AA</given-names></name> <name><surname>Mortimer</surname><given-names>AD</given-names></name> <name><surname>Hastings</surname><given-names>TG</given-names></name></person-group>. <article-title>Dopamine quinone modifies and decreases the abundance of the mitochondrial selenoprotein glutathione peroxidase 4</article-title>. <source>Free Radic Biol Med</source>. (<year>2013</year>) <volume>65</volume>:<fpage>419</fpage>&#x2013;<lpage>27</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2013.06.030</pub-id>, <pub-id pub-id-type="pmid">23816523</pub-id></mixed-citation></ref>
<ref id="ref42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>T</given-names></name> <name><surname>Xu</surname><given-names>X</given-names></name> <name><surname>Ye</surname><given-names>X</given-names></name> <name><surname>Yan</surname><given-names>J</given-names></name></person-group>. <article-title>DJ-1 upregulates the Nrf2/GPX4 signal pathway to inhibit trophoblast ferroptosis in the pathogenesis of preeclampsia</article-title>. <source>Sci Rep</source>. (<year>2022</year>) <volume>12</volume>:<fpage>2934</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-022-07065-y</pub-id>, <pub-id pub-id-type="pmid">35190654</pub-id></mixed-citation></ref>
<ref id="ref43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>P</given-names></name> <name><surname>Feng</surname><given-names>Y</given-names></name> <name><surname>Li</surname><given-names>H</given-names></name> <name><surname>Chen</surname><given-names>X</given-names></name> <name><surname>Wang</surname><given-names>G</given-names></name> <name><surname>Xu</surname><given-names>S</given-names></name> <etal/></person-group>. <article-title>Ferrostatin-1 alleviates lipopolysaccharide-induced acute lung injury via inhibiting ferroptosis</article-title>. <source>Cell Mol Biol Lett</source>. (<year>2020</year>) <volume>25</volume>:<fpage>10</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s11658-020-00205-0</pub-id></mixed-citation></ref>
<ref id="ref44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>S</given-names></name> <name><surname>Bano</surname><given-names>N</given-names></name> <name><surname>Ahamad</surname><given-names>S</given-names></name> <name><surname>John</surname><given-names>U</given-names></name> <name><surname>Dar</surname><given-names>NJ</given-names></name> <name><surname>Bhat</surname><given-names>SA</given-names></name></person-group>. <article-title>Excitotoxicity, Oxytosis/Ferroptosis, and neurodegeneration: emerging insights into mitochondrial mechanisms</article-title>. <source>Aging Dis</source>. (<year>2024</year>) <volume>16</volume>:<fpage>2504</fpage>&#x2013;<lpage>43</lpage>. doi: <pub-id pub-id-type="doi">10.14336/AD.2024.0125-1</pub-id>, <pub-id pub-id-type="pmid">39122453</pub-id></mixed-citation></ref>
<ref id="ref45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adibhatla</surname><given-names>RM</given-names></name> <name><surname>Hatcher</surname><given-names>JF</given-names></name></person-group>. <article-title>Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities</article-title>. <source>Antioxid Redox Signal</source>. (<year>2010</year>) <volume>12</volume>:<fpage>125</fpage>&#x2013;<lpage>69</lpage>. doi: <pub-id pub-id-type="doi">10.1089/ars.2009.2668</pub-id>, <pub-id pub-id-type="pmid">19624272</pub-id></mixed-citation></ref>
<ref id="ref46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattson</surname><given-names>MP</given-names></name></person-group>. <article-title>Metal-catalyzed disruption of membrane protein and lipid signaling in the pathogenesis of neurodegenerative disorders</article-title>. <source>Ann N Y Acad Sci</source>. (<year>2004</year>) <volume>1012</volume>:<fpage>37</fpage>&#x2013;<lpage>50</lpage>. doi: <pub-id pub-id-type="doi">10.1196/annals.1306.004</pub-id>, <pub-id pub-id-type="pmid">15105254</pub-id></mixed-citation></ref>
<ref id="ref47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panchal</surname><given-names>K</given-names></name> <name><surname>Tiwari</surname><given-names>AK</given-names></name></person-group>. <article-title>Mitochondrial dynamics, a key executioner in neurodegenerative diseases</article-title>. <source>Mitochondrion</source>. (<year>2019</year>) <volume>47</volume>:<fpage>151</fpage>&#x2013;<lpage>73</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.mito.2018.11.002</pub-id>, <pub-id pub-id-type="pmid">30408594</pub-id></mixed-citation></ref>
<ref id="ref48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blasco</surname><given-names>H</given-names></name> <name><surname>Garcon</surname><given-names>G</given-names></name> <name><surname>Patin</surname><given-names>F</given-names></name> <name><surname>Veyrat-Durebex</surname><given-names>C</given-names></name> <name><surname>Boyer</surname><given-names>J</given-names></name> <name><surname>Devos</surname><given-names>D</given-names></name> <etal/></person-group>. <article-title>Panel of oxidative stress and inflammatory biomarkers in ALS: a pilot study</article-title>. <source>Can J Neurol Sci</source>. (<year>2017</year>) <volume>44</volume>:<fpage>90</fpage>&#x2013;<lpage>5</lpage>. doi: <pub-id pub-id-type="doi">10.1017/cjn.2016.284</pub-id>, <pub-id pub-id-type="pmid">27774920</pub-id></mixed-citation></ref>
<ref id="ref49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonafede</surname><given-names>R</given-names></name> <name><surname>Mariotti</surname><given-names>R</given-names></name></person-group>. <article-title>ALS pathogenesis and therapeutic approaches: the role of mesenchymal stem cells and extracellular vesicles</article-title>. <source>Front Cell Neurosci</source>. (<year>2017</year>) <volume>11</volume>:<fpage>80</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fncel.2017.00080</pub-id></mixed-citation></ref>
<ref id="ref50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bono</surname><given-names>S</given-names></name> <name><surname>Feligioni</surname><given-names>M</given-names></name> <name><surname>Corbo</surname><given-names>M</given-names></name></person-group>. <article-title>Impaired antioxidant KEAP1-NRF2 system in amyotrophic lateral sclerosis: NRF2 activation as a potential therapeutic strategy</article-title>. <source>Mol Neurodegener</source>. (<year>2021</year>) <volume>16</volume>:<fpage>71</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13024-021-00479-8</pub-id>, <pub-id pub-id-type="pmid">34663413</pub-id></mixed-citation></ref>
<ref id="ref51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brandes</surname><given-names>MS</given-names></name> <name><surname>Gray</surname><given-names>NE</given-names></name></person-group>. <article-title>NRF2 as a therapeutic target in neurodegenerative diseases</article-title>. <source>ASN Neuro</source>. (<year>2020</year>) <volume>12</volume>:<fpage>1759091419899782</fpage>. doi: <pub-id pub-id-type="doi">10.1177/1759091419899782</pub-id></mixed-citation></ref>
<ref id="ref52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ross</surname><given-names>CA</given-names></name> <name><surname>Tabrizi</surname><given-names>SJ</given-names></name></person-group>. <article-title>Huntington's disease: from molecular pathogenesis to clinical treatment</article-title>. <source>Lancet Neurol</source>. (<year>2011</year>) <volume>10</volume>:<fpage>83</fpage>&#x2013;<lpage>98</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S1474-4422(10)70245-3</pub-id>, <pub-id pub-id-type="pmid">21163446</pub-id></mixed-citation></ref>
<ref id="ref53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tabrizi</surname><given-names>SJ</given-names></name> <name><surname>Leavitt</surname><given-names>BR</given-names></name> <name><surname>Landwehrmeyer</surname><given-names>GB</given-names></name> <name><surname>Wild</surname><given-names>EJ</given-names></name> <name><surname>Saft</surname><given-names>C</given-names></name> <name><surname>Barker</surname><given-names>RA</given-names></name> <etal/></person-group>. <article-title>Targeting Huntingtin Expression in Patients with Huntington&#x2019;s Disease</article-title>. <source>N Engl J Med</source>. (<year>2019</year>) <volume>380</volume>:<fpage>2307</fpage>&#x2013;<lpage>16</lpage>. doi: <pub-id pub-id-type="doi">10.1056/NEJMx190024</pub-id></mixed-citation></ref>
<ref id="ref54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tabrizi</surname><given-names>SJ</given-names></name> <name><surname>Flower</surname><given-names>MD</given-names></name> <name><surname>Ross</surname><given-names>CA</given-names></name> <name><surname>Wild</surname><given-names>EJ</given-names></name></person-group>. <article-title>Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities</article-title>. <source>Nat Rev Neurol</source>. (<year>2020</year>) <volume>16</volume>:<fpage>529</fpage>&#x2013;<lpage>46</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41582-020-0389-4</pub-id>, <pub-id pub-id-type="pmid">32796930</pub-id></mixed-citation></ref>
<ref id="ref55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sayed</surname><given-names>NH</given-names></name> <name><surname>Fathy</surname><given-names>N</given-names></name> <name><surname>Kortam</surname><given-names>MA</given-names></name> <name><surname>Rabie</surname><given-names>MA</given-names></name> <name><surname>Mohamed</surname><given-names>AF</given-names></name> <name><surname>Kamel</surname><given-names>AS</given-names></name></person-group>. <article-title>Vildagliptin attenuates Huntington's disease through activation of GLP-1 receptor/PI3K/Akt/BDNF pathway in 3-Nitropropionic acid rat model</article-title>. <source>Neurotherapeutics</source>. (<year>2020</year>) <volume>17</volume>:<fpage>252</fpage>&#x2013;<lpage>68</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s13311-019-00805-5</pub-id>, <pub-id pub-id-type="pmid">31728850</pub-id></mixed-citation></ref>
<ref id="ref56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rotblat</surname><given-names>B</given-names></name> <name><surname>Southwell</surname><given-names>AL</given-names></name> <name><surname>Ehrnhoefer</surname><given-names>DE</given-names></name> <name><surname>Skotte</surname><given-names>NH</given-names></name> <name><surname>Metzler</surname><given-names>M</given-names></name> <name><surname>Franciosi</surname><given-names>S</given-names></name> <etal/></person-group>. <article-title>HACE1 reduces oxidative stress and mutant huntingtin toxicity by promoting the NRF2 response</article-title>. <source>Proc Natl Acad Sci USA</source>. (<year>2014</year>) <volume>111</volume>:<fpage>3032</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.1314421111</pub-id>, <pub-id pub-id-type="pmid">24516159</pub-id></mixed-citation></ref>
<ref id="ref57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mi</surname><given-names>Y</given-names></name> <name><surname>Gao</surname><given-names>X</given-names></name> <name><surname>Xu</surname><given-names>H</given-names></name> <name><surname>Cui</surname><given-names>Y</given-names></name> <name><surname>Zhang</surname><given-names>Y</given-names></name> <name><surname>Gou</surname><given-names>X</given-names></name></person-group>. <article-title>The emerging roles of Ferroptosis in Huntington's disease</article-title>. <source>NeuroMolecular Med</source>. (<year>2019</year>) <volume>21</volume>:<fpage>110</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s12017-018-8518-6</pub-id>, <pub-id pub-id-type="pmid">30600476</pub-id></mixed-citation></ref>
<ref id="ref58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuwar</surname><given-names>OK</given-names></name> <name><surname>Kalia</surname><given-names>N</given-names></name></person-group>. <article-title>Anti-inflammatory and antioxidant effects of baicalein: targeting Nrf2, and NF&#x0138;B in neurodegenerative disease</article-title>. <source>Inflammopharmacology</source>. (<year>2025</year>) <volume>33</volume>:<fpage>1303</fpage>&#x2013;<lpage>10</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10787-025-01698-x</pub-id>, <pub-id pub-id-type="pmid">40014253</pub-id></mixed-citation></ref>
<ref id="ref59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esteras</surname><given-names>N</given-names></name> <name><surname>Abramov</surname><given-names>AY</given-names></name></person-group>. <article-title>Nrf2 as a regulator of mitochondrial function: energy metabolism and beyond</article-title>. <source>Free Radic Biol Med</source>. (<year>2022</year>) <volume>189</volume>:<fpage>136</fpage>&#x2013;<lpage>53</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2022.07.013</pub-id>, <pub-id pub-id-type="pmid">35918014</pub-id></mixed-citation></ref>
<ref id="ref60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhat</surname><given-names>SA</given-names></name> <name><surname>Ahamad</surname><given-names>S</given-names></name> <name><surname>Dar</surname><given-names>NJ</given-names></name> <name><surname>Siddique</surname><given-names>YH</given-names></name> <name><surname>Nazir</surname><given-names>A</given-names></name></person-group>. <article-title>The emerging landscape of natural small-molecule therapeutics for Huntington's disease</article-title>. <source>Curr Neuropharmacol</source>. (<year>2023</year>) <volume>21</volume>:<fpage>867</fpage>&#x2013;<lpage>89</lpage>. doi: <pub-id pub-id-type="doi">10.2174/1570159X21666230216104621</pub-id>, <pub-id pub-id-type="pmid">36797612</pub-id></mixed-citation></ref>
<ref id="ref61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>S</given-names></name> <name><surname>Shen</surname><given-names>J</given-names></name> <name><surname>Jiang</surname><given-names>J</given-names></name> <name><surname>Wang</surname><given-names>F</given-names></name> <name><surname>Min</surname><given-names>J</given-names></name></person-group>. <article-title>Targeting ferroptosis opens new avenues for the development of novel therapeutics</article-title>. <source>Signal Transduct Target Ther</source>. (<year>2023</year>) <volume>8</volume>:<fpage>372</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41392-023-01606-1</pub-id>, <pub-id pub-id-type="pmid">37735472</pub-id></mixed-citation></ref>
<ref id="ref62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dixon</surname><given-names>SJ</given-names></name> <name><surname>Olzmann</surname><given-names>JA</given-names></name></person-group>. <article-title>The cell biology of ferroptosis</article-title>. <source>Nat Rev Mol Cell Biol</source>. (<year>2024</year>) <volume>25</volume>:<fpage>424</fpage>&#x2013;<lpage>42</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41580-024-00703-5</pub-id>, <pub-id pub-id-type="pmid">38366038</pub-id></mixed-citation></ref>
<ref id="ref63"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>XS</given-names></name> <name><surname>Gao</surname><given-names>L</given-names></name> <name><surname>Han</surname><given-names>Z</given-names></name> <name><surname>Eleuteri</surname><given-names>S</given-names></name> <name><surname>Shi</surname><given-names>W</given-names></name> <name><surname>Shen</surname><given-names>Y</given-names></name> <etal/></person-group>. <article-title>Ferroptosis in Parkinson's disease: molecular mechanisms and therapeutic potential</article-title>. <source>Ageing Res Rev</source>. (<year>2023</year>) <volume>91</volume>:<fpage>102077</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.arr.2023.102077</pub-id></mixed-citation></ref>
<ref id="ref64"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>B</given-names></name> <name><surname>Zandkarimi</surname><given-names>F</given-names></name> <name><surname>Bezjian</surname><given-names>CT</given-names></name> <name><surname>Reznik</surname><given-names>E</given-names></name> <name><surname>Soni</surname><given-names>RK</given-names></name> <name><surname>Gu</surname><given-names>W</given-names></name> <etal/></person-group>. <article-title>Phospholipids with two polyunsaturated fatty acyl tails promote ferroptosis</article-title>. <source>Cell</source>. (<year>2024</year>) <volume>187</volume>:<fpage>1177</fpage>&#x2013;<lpage>90.e18</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2024.01.030</pub-id>, <pub-id pub-id-type="pmid">38366593</pub-id></mixed-citation></ref>
<ref id="ref65"><label>65.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pope</surname><given-names>LE</given-names></name> <name><surname>Dixon</surname><given-names>SJ</given-names></name></person-group>. <article-title>Regulation of ferroptosis by lipid metabolism</article-title>. <source>Trends Cell Biol</source>. (<year>2023</year>) <volume>33</volume>:<fpage>1077</fpage>&#x2013;<lpage>87</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.tcb.2023.05.003</pub-id>, <pub-id pub-id-type="pmid">37407304</pub-id></mixed-citation></ref>
<ref id="ref66"><label>66.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mortensen</surname><given-names>MS</given-names></name> <name><surname>Ruiz</surname><given-names>J</given-names></name> <name><surname>Watts</surname><given-names>JL</given-names></name></person-group>. <article-title>Polyunsaturated fatty acids drive lipid peroxidation during Ferroptosis</article-title>. <source>Cells</source>. (<year>2023</year>) <volume>12</volume>:<fpage>804</fpage>. doi: <pub-id pub-id-type="doi">10.3390/cells12050804</pub-id>, <pub-id pub-id-type="pmid">36899940</pub-id></mixed-citation></ref>
<ref id="ref67"><label>67.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tripathi</surname><given-names>AK</given-names></name> <name><surname>Karmakar</surname><given-names>S</given-names></name> <name><surname>Asthana</surname><given-names>A</given-names></name> <name><surname>Ashok</surname><given-names>A</given-names></name> <name><surname>Desai</surname><given-names>V</given-names></name> <name><surname>Baksi</surname><given-names>S</given-names></name> <etal/></person-group>. <article-title>Transport of non-transferrin bound Iron to the brain: implications for Alzheimer's disease</article-title>. <source>J Alzheimer's Dis</source>. (<year>2017</year>) <volume>58</volume>:<fpage>1109</fpage>&#x2013;<lpage>19</lpage>. doi: <pub-id pub-id-type="doi">10.3233/JAD-170097</pub-id>, <pub-id pub-id-type="pmid">28550259</pub-id></mixed-citation></ref>
<ref id="ref68"><label>68.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>YJ</given-names></name> <name><surname>Liu</surname><given-names>XY</given-names></name> <name><surname>Xing</surname><given-names>L</given-names></name> <name><surname>Wan</surname><given-names>X</given-names></name> <name><surname>Chang</surname><given-names>X</given-names></name> <name><surname>Jiang</surname><given-names>HL</given-names></name></person-group>. <article-title>Fenton reaction-independent ferroptosis therapy via glutathione and iron redox couple sequentially triggered lipid peroxide generator</article-title>. <source>Biomaterials</source>. (<year>2020</year>) <volume>241</volume>:<fpage>119911</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.biomaterials.2020.119911</pub-id></mixed-citation></ref>
<ref id="ref69"><label>69.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>H</given-names></name> <name><surname>Dong</surname><given-names>Y</given-names></name> <name><surname>Chu</surname><given-names>Y</given-names></name> <name><surname>Guo</surname><given-names>Y</given-names></name> <name><surname>Li</surname><given-names>L</given-names></name></person-group>. <article-title>The mechanisms of ferroptosis and its role in alzheimer's disease</article-title>. <source>Front Mol Biosci</source>. (<year>2022</year>) <volume>9</volume>:<fpage>965064</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmolb.2022.965064</pub-id></mixed-citation></ref>
<ref id="ref70"><label>70.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>Z</given-names></name> <name><surname>Zhang</surname><given-names>S</given-names></name> <name><surname>Liu</surname><given-names>X</given-names></name> <name><surname>Wang</surname><given-names>X</given-names></name> <name><surname>Xue</surname><given-names>C</given-names></name> <name><surname>Wu</surname><given-names>X</given-names></name> <etal/></person-group>. <article-title>LRRK2 regulates ferroptosis through the system xc-GSH-GPX4 pathway in the neuroinflammatory mechanism of Parkinson's disease</article-title>. <source>J Cell Physiol</source>. (<year>2024</year>) <volume>239</volume>:<fpage>e31250</fpage>. doi: <pub-id pub-id-type="doi">10.1002/jcp.31250</pub-id>, <pub-id pub-id-type="pmid">38477420</pub-id></mixed-citation></ref>
<ref id="ref71"><label>71.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russo</surname><given-names>A</given-names></name> <name><surname>Putaggio</surname><given-names>S</given-names></name> <name><surname>Tellone</surname><given-names>E</given-names></name> <name><surname>Calderaro</surname><given-names>A</given-names></name> <name><surname>Cirmi</surname><given-names>S</given-names></name> <name><surname>Lagan&#x00E0;</surname><given-names>G</given-names></name> <etal/></person-group>. <article-title>Emerging ferroptosis involvement in amyotrophic lateral sclerosis pathogenesis: neuroprotective activity of polyphenols</article-title>. <source>Molecules</source>. (<year>2025</year>) <volume>30</volume>:<fpage>1211</fpage>. doi: <pub-id pub-id-type="doi">10.3390/molecules30061211</pub-id>, <pub-id pub-id-type="pmid">40141987</pub-id></mixed-citation></ref>
<ref id="ref72"><label>72.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name> <name><surname>Liu</surname><given-names>Y</given-names></name> <name><surname>Du</surname><given-names>T</given-names></name> <name><surname>Yang</surname><given-names>H</given-names></name> <name><surname>Lei</surname><given-names>L</given-names></name> <name><surname>Guo</surname><given-names>M</given-names></name> <etal/></person-group>. <article-title>ATF3 promotes erastin-induced ferroptosis by suppressing system xc()</article-title>. <source>Cell Death Differ</source>. (<year>2020</year>) <volume>27</volume>:<fpage>662</fpage>&#x2013;<lpage>75</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41418-019-0380-z</pub-id>, <pub-id pub-id-type="pmid">31273299</pub-id></mixed-citation></ref>
<ref id="ref73"><label>73.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seibt</surname><given-names>TM</given-names></name> <name><surname>Proneth</surname><given-names>B</given-names></name> <name><surname>Conrad</surname><given-names>M</given-names></name></person-group>. <article-title>Role of GPX4 in ferroptosis and its pharmacological implication</article-title>. <source>Free Radic Biol Med</source>. (<year>2019</year>) <volume>133</volume>:<fpage>144</fpage>&#x2013;<lpage>52</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2018.09.014</pub-id>, <pub-id pub-id-type="pmid">30219704</pub-id></mixed-citation></ref>
<ref id="ref74"><label>74.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rochette</surname><given-names>L</given-names></name> <name><surname>Dogon</surname><given-names>G</given-names></name> <name><surname>Rigal</surname><given-names>E</given-names></name> <name><surname>Zeller</surname><given-names>M</given-names></name> <name><surname>Cottin</surname><given-names>Y</given-names></name> <name><surname>Vergely</surname><given-names>C</given-names></name></person-group>. <article-title>Lipid peroxidation and iron metabolism: two corner stones in the homeostasis control of ferroptosis</article-title>. <source>Int J Mol Sci</source>. (<year>2022</year>) <volume>24</volume>:<fpage>449</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms24010449</pub-id>, <pub-id pub-id-type="pmid">36613888</pub-id></mixed-citation></ref>
<ref id="ref75"><label>75.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuadrado</surname><given-names>A</given-names></name> <name><surname>Rojo</surname><given-names>AI</given-names></name> <name><surname>Wells</surname><given-names>G</given-names></name> <name><surname>Hayes</surname><given-names>JD</given-names></name> <name><surname>Cousin</surname><given-names>SP</given-names></name> <name><surname>Rumsey</surname><given-names>WL</given-names></name> <etal/></person-group>. <article-title>Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases</article-title>. <source>Nat Rev Drug Discov</source>. (<year>2019</year>) <volume>18</volume>:<fpage>295</fpage>&#x2013;<lpage>317</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41573-018-0008-x</pub-id>, <pub-id pub-id-type="pmid">30610225</pub-id></mixed-citation></ref>
<ref id="ref76"><label>76.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Y</given-names></name> <name><surname>Xu</surname><given-names>L</given-names></name> <name><surname>Zheng</surname><given-names>D</given-names></name> <name><surname>Wang</surname><given-names>J</given-names></name> <name><surname>Liu</surname><given-names>G</given-names></name> <name><surname>Mo</surname><given-names>Z</given-names></name> <etal/></person-group>. <article-title>A potent phosphodiester Keap1-Nrf2 protein-protein interaction inhibitor as the efficient treatment of Alzheimer's disease</article-title>. <source>Redox Biol</source>. (<year>2023</year>) <volume>64</volume>:<fpage>102793</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.redox.2023.102793</pub-id>, <pub-id pub-id-type="pmid">37385075</pub-id></mixed-citation></ref>
<ref id="ref77"><label>77.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>Q</given-names></name> <name><surname>Xing</surname><given-names>J</given-names></name> <name><surname>Li</surname><given-names>X</given-names></name> <name><surname>Tang</surname><given-names>X</given-names></name> <name><surname>Zhang</surname><given-names>D</given-names></name></person-group>. <article-title>PRDM16 suppresses ferroptosis to protect against sepsis-associated acute kidney injury by targeting the NRF2/GPX4 axis</article-title>. <source>Redox Biol</source>. (<year>2024</year>) <volume>78</volume>:<fpage>103417</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.redox.2024.103417</pub-id>, <pub-id pub-id-type="pmid">39549609</pub-id></mixed-citation></ref>
<ref id="ref78"><label>78.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>GH</given-names></name> <name><surname>Song</surname><given-names>CC</given-names></name> <name><surname>Pantopoulos</surname><given-names>K</given-names></name> <name><surname>Wei</surname><given-names>XL</given-names></name> <name><surname>Zheng</surname><given-names>H</given-names></name> <name><surname>Luo</surname><given-names>Z</given-names></name></person-group>. <article-title>Mitochondrial oxidative stress mediated Fe-induced ferroptosis via the NRF2-ARE pathway</article-title>. <source>Free Radic Biol Med</source>. (<year>2022</year>) <volume>180</volume>:<fpage>95</fpage>&#x2013;<lpage>107</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2022.01.012</pub-id>, <pub-id pub-id-type="pmid">35045311</pub-id></mixed-citation></ref>
<ref id="ref79"><label>79.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>XC</given-names></name> <name><surname>Jin</surname><given-names>YJ</given-names></name> <name><surname>Ning</surname><given-names>R</given-names></name> <name><surname>Mao</surname><given-names>QY</given-names></name> <name><surname>Zhang</surname><given-names>PY</given-names></name> <name><surname>Zhou</surname><given-names>L</given-names></name> <etal/></person-group>. <article-title>Electroacupuncture attenuates ferroptosis by promoting Nrf2 nuclear translocation and activating Nrf2/SLC7A11/GPX4 pathway in ischemic stroke</article-title>. <source>Chin Med</source>. (<year>2025</year>) <volume>20</volume>:<fpage>4</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13020-024-01047-0</pub-id>, <pub-id pub-id-type="pmid">39755657</pub-id></mixed-citation></ref>
<ref id="ref80"><label>80.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>Q</given-names></name> <name><surname>Huang</surname><given-names>D</given-names></name> <name><surname>Zhao</surname><given-names>L</given-names></name> <name><surname>Long</surname><given-names>X</given-names></name> <name><surname>Tu</surname><given-names>Q</given-names></name> <name><surname>Song</surname><given-names>L</given-names></name> <etal/></person-group>. <article-title>Groundbreaking insights into SIRT1/NRF2-mediated ferroptosis inhibition by resveratrol in Parkinson's disease models</article-title>. <source>CNS Neurosci Ther</source>. (<year>2025</year>) <volume>31</volume>:<fpage>e70648</fpage>. doi: <pub-id pub-id-type="doi">10.1111/cns.70648</pub-id>, <pub-id pub-id-type="pmid">41220093</pub-id></mixed-citation></ref>
<ref id="ref81"><label>81.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Z</given-names></name> <name><surname>Lv</surname><given-names>X</given-names></name> <name><surname>Song</surname><given-names>E</given-names></name> <name><surname>Song</surname><given-names>Y</given-names></name></person-group>. <article-title>Fostered Nrf2 expression antagonizes iron overload and glutathione depletion to promote resistance of neuron-like cells to ferroptosis</article-title>. <source>Toxicol Appl Pharmacol</source>. (<year>2020</year>) <volume>407</volume>:<fpage>115241</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.taap.2020.115241</pub-id></mixed-citation></ref>
<ref id="ref82"><label>82.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghafouri-Fard</surname><given-names>S</given-names></name> <name><surname>Shoorei</surname><given-names>H</given-names></name> <name><surname>Bahroudi</surname><given-names>Z</given-names></name> <name><surname>Hussen</surname><given-names>BM</given-names></name> <name><surname>Talebi</surname><given-names>SF</given-names></name> <name><surname>Taheri</surname><given-names>M</given-names></name> <etal/></person-group>. <article-title>Nrf2-related therapeutic effects of curcumin in different disorders</article-title>. <source>Biomolecules</source>. (<year>2022</year>) <volume>12</volume>:<fpage>82</fpage>. doi: <pub-id pub-id-type="doi">10.3390/biom12010082</pub-id>, <pub-id pub-id-type="pmid">35053230</pub-id></mixed-citation></ref>
<ref id="ref83"><label>83.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shahcheraghi</surname><given-names>SH</given-names></name> <name><surname>Salemi</surname><given-names>F</given-names></name> <name><surname>Peirovi</surname><given-names>N</given-names></name> <name><surname>Ayatollahi</surname><given-names>J</given-names></name> <name><surname>Alam</surname><given-names>W</given-names></name> <name><surname>Khan</surname><given-names>H</given-names></name> <etal/></person-group>. <article-title>Nrf2 regulation by curcumin: molecular aspects for therapeutic prospects</article-title>. <source>Molecules</source>. (<year>2021</year>) <volume>27</volume>:<fpage>27(1)</fpage>. doi: <pub-id pub-id-type="doi">10.3390/molecules27010167</pub-id>, <pub-id pub-id-type="pmid">35011412</pub-id></mixed-citation></ref>
<ref id="ref84"><label>84.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name> <name><surname>Sung</surname><given-names>P</given-names></name> <name><surname>Zhang</surname><given-names>D</given-names></name> <name><surname>Yan</surname><given-names>L</given-names></name></person-group>. <article-title>Curcumin in vitro neuroprotective effects are mediated by p62/keap-1/Nrf2 and PI3K/AKT signaling pathway and autophagy inhibition</article-title>. <source>Physiol Res</source>. (<year>2023</year>) <volume>72</volume>:<fpage>497</fpage>&#x2013;<lpage>510</lpage>. doi: <pub-id pub-id-type="doi">10.33549/physiolres.935054</pub-id> <pub-id pub-id-type="pmid">37795892</pub-id></mixed-citation></ref>
<ref id="ref85"><label>85.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duan</surname><given-names>C</given-names></name> <name><surname>Wang</surname><given-names>H</given-names></name> <name><surname>Jiao</surname><given-names>D</given-names></name> <name><surname>Geng</surname><given-names>Y</given-names></name> <name><surname>Wu</surname><given-names>Q</given-names></name> <name><surname>Yan</surname><given-names>H</given-names></name> <etal/></person-group>. <article-title>Curcumin restrains oxidative stress of after intracerebral hemorrhage in rat by activating the Nrf2/HO-1 pathway</article-title>. <source>Front Pharmacol</source>. (<year>2022</year>) <volume>13</volume>:<fpage>889226</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fphar.2022.889226</pub-id></mixed-citation></ref>
<ref id="ref86"><label>86.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agrawal</surname><given-names>KK</given-names></name> <name><surname>Veer</surname><given-names>C</given-names></name> <name><surname>Murti</surname><given-names>Y</given-names></name> <name><surname>Singh</surname><given-names>SP</given-names></name></person-group>. <article-title>Lead Phytomolecules for treating Parkinson's disease</article-title>. <source>Cent Nerv Syst Agents Med Chem</source>. (<year>2025</year>) <volume>25</volume>:<fpage>337</fpage>&#x2013;<lpage>61</lpage>. doi: <pub-id pub-id-type="doi">10.2174/0118715249355503241210101001</pub-id>, <pub-id pub-id-type="pmid">39698888</pub-id></mixed-citation></ref>
<ref id="ref87"><label>87.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moinipour</surname><given-names>N</given-names></name> <name><surname>Barati</surname><given-names>M</given-names></name> <name><surname>Sahebkar</surname><given-names>A</given-names></name> <name><surname>Iranshahy</surname><given-names>M</given-names></name> <name><surname>Shakeri</surname><given-names>A</given-names></name></person-group>. <article-title>Protective effects of curcumin against Iron-induced toxicity</article-title>. <source>Curr Pharm Biotechnol</source>. (<year>2022</year>) <volume>23</volume>:<fpage>1020</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.2174/1389201022666210914122846</pub-id>, <pub-id pub-id-type="pmid">34521323</pub-id></mixed-citation></ref>
<ref id="ref88"><label>88.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name> <name><surname>Shen</surname><given-names>Q</given-names></name> <name><surname>Liu</surname><given-names>Y</given-names></name> <name><surname>Zhang</surname><given-names>Y</given-names></name> <name><surname>Sun</surname><given-names>L</given-names></name> <name><surname>Ma</surname><given-names>X</given-names></name> <etal/></person-group>. <article-title>Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases</article-title>. <source>Signal Transduct Target Ther</source>. (<year>2025</year>) <volume>10</volume>:<fpage>31</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41392-024-02071-0</pub-id>, <pub-id pub-id-type="pmid">39894843</pub-id></mixed-citation></ref>
<ref id="ref89"><label>89.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gagliardi</surname><given-names>S</given-names></name> <name><surname>Morasso</surname><given-names>C</given-names></name> <name><surname>Stivaktakis</surname><given-names>P</given-names></name> <name><surname>Pandini</surname><given-names>C</given-names></name> <name><surname>Tinelli</surname><given-names>V</given-names></name> <name><surname>Tsatsakis</surname><given-names>A</given-names></name> <etal/></person-group>. <article-title>Curcumin formulations and trials: what's new in neurological diseases</article-title>. <source>Molecules</source>. (<year>2020</year>) <volume>25</volume>:<fpage>5389</fpage>. doi: <pub-id pub-id-type="doi">10.3390/molecules25225389</pub-id>, <pub-id pub-id-type="pmid">33217959</pub-id></mixed-citation></ref>
<ref id="ref90"><label>90.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>J</given-names></name> <name><surname>Wen</surname><given-names>C</given-names></name> <name><surname>Lu</surname><given-names>Y</given-names></name> <name><surname>Fan</surname><given-names>X</given-names></name> <name><surname>Dang</surname><given-names>R</given-names></name> <name><surname>Chu</surname><given-names>J</given-names></name> <etal/></person-group>. <article-title>Alliin from garlic as a neuroprotective agent attenuates ferroptosis in vitro and in vivo via inhibiting ALOX15</article-title>. <source>Food Funct</source>. (<year>2025</year>) <volume>16</volume>:<fpage>5278</fpage>&#x2013;<lpage>300</lpage>. doi: <pub-id pub-id-type="doi">10.1039/d5fo00425j</pub-id>, <pub-id pub-id-type="pmid">40396992</pub-id></mixed-citation></ref>
<ref id="ref91"><label>91.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagai</surname><given-names>S</given-names></name> <name><surname>Yoshida</surname><given-names>M</given-names></name> <name><surname>Takigawa</surname><given-names>Y</given-names></name> <name><surname>Torii</surname><given-names>S</given-names></name> <name><surname>Koshiishi</surname><given-names>I</given-names></name></person-group>. <article-title>Botanical sulfane sulfur donors inhibit ferroptotic cell death caused by the depletion of cysteine</article-title>. <source>Food Chem</source>. (<year>2021</year>) <volume>343</volume>:<fpage>128511</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.foodchem.2020.128511</pub-id></mixed-citation></ref>
<ref id="ref92"><label>92.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>SS</given-names></name> <name><surname>Song</surname><given-names>JH</given-names></name> <name><surname>Hwang</surname><given-names>B</given-names></name> <name><surname>Noh</surname><given-names>DH</given-names></name> <name><surname>Park</surname><given-names>SL</given-names></name> <name><surname>Kim</surname><given-names>WT</given-names></name> <etal/></person-group>. <article-title>HSPA6 augments garlic extract-induced inhibition of proliferation, migration, and invasion of bladder cancer EJ cells; implication for cell cycle dysregulation, signaling pathway alteration, and transcription factor-associated MMP-9 regulation</article-title>. <source>PLoS One</source>. (<year>2017</year>) <volume>12</volume>:<fpage>e0171860</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0171860</pub-id>, <pub-id pub-id-type="pmid">28187175</pub-id></mixed-citation></ref>
<ref id="ref93"><label>93.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>SG</given-names></name> <name><surname>Ren</surname><given-names>PY</given-names></name> <name><surname>Wang</surname><given-names>GY</given-names></name> <name><surname>Yao</surname><given-names>SX</given-names></name> <name><surname>He</surname><given-names>XJ</given-names></name></person-group>. <article-title>Allicin protects spinal cord neurons from glutamate-induced oxidative stress through regulating the heat shock protein 70/inducible nitric oxide synthase pathway</article-title>. <source>Food Funct</source>. (<year>2015</year>) <volume>6</volume>:<fpage>321</fpage>&#x2013;<lpage>30</lpage>. doi: <pub-id pub-id-type="doi">10.1039/c4fo00761a</pub-id>, <pub-id pub-id-type="pmid">25473931</pub-id></mixed-citation></ref>
<ref id="ref94"><label>94.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bigham</surname><given-names>M</given-names></name> <name><surname>Mohammadipour</surname><given-names>A</given-names></name> <name><surname>Hosseini</surname><given-names>M</given-names></name> <name><surname>Malvandi</surname><given-names>AM</given-names></name> <name><surname>Ebrahimzadeh-Bideskan</surname><given-names>A</given-names></name></person-group>. <article-title>Neuroprotective effects of garlic extract on dopaminergic neurons of substantia nigra in a rat model of Parkinson's disease: motor and non-motor outcomes</article-title>. <source>Metab Brain Dis</source>. (<year>2021</year>) <volume>36</volume>:<fpage>927</fpage>&#x2013;<lpage>37</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11011-021-00705-8</pub-id>, <pub-id pub-id-type="pmid">33656625</pub-id></mixed-citation></ref>
<ref id="ref95"><label>95.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hegazy</surname><given-names>EM</given-names></name> <name><surname>Sabry</surname><given-names>A</given-names></name> <name><surname>Khalil</surname><given-names>WKB</given-names></name></person-group>. <article-title>Neuroprotective effects of onion and garlic root extracts against Alzheimer's disease in rats: antimicrobial, histopathological, and molecular studies</article-title>. <source>BioTechnologia</source>. (<year>2022</year>) <volume>103</volume>:<fpage>153</fpage>&#x2013;<lpage>67</lpage>. doi: <pub-id pub-id-type="doi">10.5114/bta.2022.116210</pub-id>, <pub-id pub-id-type="pmid">36606073</pub-id></mixed-citation></ref>
<ref id="ref96"><label>96.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hiramatsu</surname><given-names>K</given-names></name> <name><surname>Tsuneyoshi</surname><given-names>T</given-names></name> <name><surname>Ogawa</surname><given-names>T</given-names></name> <name><surname>Morihara</surname><given-names>N</given-names></name></person-group>. <article-title>Aged garlic extract enhances heme oxygenase-1 and glutamate-cysteine ligase modifier subunit expression via the nuclear factor erythroid 2-related factor 2-antioxidant response element signaling pathway in human endothelial cells</article-title>. <source>Nutr Res</source>. (<year>2016</year>) <volume>36</volume>:<fpage>143</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.nutres.2015.09.018</pub-id>, <pub-id pub-id-type="pmid">26507778</pub-id></mixed-citation></ref>
<ref id="ref97"><label>97.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>H</given-names></name> <name><surname>Lu</surname><given-names>Y</given-names></name> <name><surname>Qu</surname><given-names>Z</given-names></name> <name><surname>Mossine</surname><given-names>VV</given-names></name> <name><surname>Martin</surname><given-names>MB</given-names></name> <name><surname>Hou</surname><given-names>J</given-names></name> <etal/></person-group>. <article-title>Effects of aged garlic extract and FruArg on gene expression and signaling pathways in lipopolysaccharide-activated microglial cells</article-title>. <source>Sci Rep</source>. (<year>2016</year>) <volume>6</volume>:<fpage>35323</fpage>. doi: <pub-id pub-id-type="doi">10.1038/srep35323</pub-id></mixed-citation></ref>
<ref id="ref98"><label>98.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gruenwald</surname><given-names>J</given-names></name> <name><surname>Freder</surname><given-names>J</given-names></name> <name><surname>Armbruester</surname><given-names>N</given-names></name></person-group>. <article-title>Cinnamon and health</article-title>. <source>Crit Rev Food Sci Nutr</source>. (<year>2010</year>) <volume>50</volume>:<fpage>822</fpage>&#x2013;<lpage>34</lpage>. doi: <pub-id pub-id-type="doi">10.1080/10408390902773052</pub-id>, <pub-id pub-id-type="pmid">20924865</pub-id></mixed-citation></ref>
<ref id="ref99"><label>99.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khaafi</surname><given-names>M</given-names></name> <name><surname>Tayarani-Najaran</surname><given-names>Z</given-names></name> <name><surname>Javadi</surname><given-names>B</given-names></name></person-group>. <article-title>Cinnamaldehyde as a promising dietary phytochemical against metabolic syndrome: a systematic review</article-title>. <source>Mini Rev Med Chem</source>. (<year>2024</year>) <volume>24</volume>:<fpage>355</fpage>&#x2013;<lpage>69</lpage>. doi: <pub-id pub-id-type="doi">10.2174/1389557523666230725113446</pub-id>, <pub-id pub-id-type="pmid">37489782</pub-id></mixed-citation></ref>
<ref id="ref100"><label>100.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nile</surname><given-names>A</given-names></name> <name><surname>Shin</surname><given-names>J</given-names></name> <name><surname>Shin</surname><given-names>J</given-names></name> <name><surname>Park</surname><given-names>GS</given-names></name> <name><surname>Lee</surname><given-names>S</given-names></name> <name><surname>Lee</surname><given-names>JH</given-names></name> <etal/></person-group>. <article-title>Cinnamaldehyde-rich cinnamon extract induces cell death in colon cancer cell lines HCT 116 and HT-29</article-title>. <source>Int J Mol Sci</source>. (<year>2023</year>) <volume>24</volume>:<fpage>8191</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms24098191</pub-id>, <pub-id pub-id-type="pmid">37175897</pub-id></mixed-citation></ref>
<ref id="ref101"><label>101.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denkova-Kostova</surname><given-names>R</given-names></name> <name><surname>Teneva</surname><given-names>D</given-names></name> <name><surname>Tomova</surname><given-names>T</given-names></name> <name><surname>Goranov</surname><given-names>B</given-names></name> <name><surname>Denkova</surname><given-names>Z</given-names></name> <name><surname>Shopska</surname><given-names>V</given-names></name> <etal/></person-group>. <article-title>Chemical composition, antioxidant and antimicrobial activity of essential oils from tangerine (<italic>Citrus reticulata</italic> L.), grapefruit (<italic>Citrus paradisi</italic> L.), lemon (<italic>Citrus lemon</italic> L.) and cinnamon (<italic>Cinnamomum zeylanicum</italic> Blume)</article-title>. <source>Z Naturforsch C J Biosci</source>. (<year>2021</year>) <volume>76</volume>:<fpage>175</fpage>&#x2013;<lpage>85</lpage>. doi: <pub-id pub-id-type="doi">10.1515/znc-2020-0126</pub-id>, <pub-id pub-id-type="pmid">33909955</pub-id></mixed-citation></ref>
<ref id="ref102"><label>102.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wondrak</surname><given-names>GT</given-names></name> <name><surname>Cabello</surname><given-names>CM</given-names></name> <name><surname>Villeneuve</surname><given-names>NF</given-names></name> <name><surname>Zhang</surname><given-names>S</given-names></name> <name><surname>Ley</surname><given-names>S</given-names></name> <name><surname>Li</surname><given-names>Y</given-names></name> <etal/></person-group>. <article-title>Cinnamoyl-based Nrf2-activators targeting human skin cell photo-oxidative stress</article-title>. <source>Free Radic Biol Med</source>. (<year>2008</year>) <volume>45</volume>:<fpage>385</fpage>&#x2013;<lpage>95</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2008.04.023</pub-id>, <pub-id pub-id-type="pmid">18482591</pub-id></mixed-citation></ref>
<ref id="ref103"><label>103.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masutani</surname><given-names>H</given-names></name> <name><surname>Otsuki</surname><given-names>R</given-names></name> <name><surname>Yamaguchi</surname><given-names>Y</given-names></name> <name><surname>Takenaka</surname><given-names>M</given-names></name> <name><surname>Kanoh</surname><given-names>N</given-names></name> <name><surname>Takatera</surname><given-names>K</given-names></name> <etal/></person-group>. <article-title>Fragrant unsaturated aldehydes elicit activation of the Keap1/Nrf2 system leading to the upregulation of thioredoxin expression and protection against oxidative stress</article-title>. <source>Antioxid Redox Signal</source>. (<year>2009</year>) <volume>11</volume>:<fpage>949</fpage>&#x2013;<lpage>62</lpage>. doi: <pub-id pub-id-type="doi">10.1089/ars.2008.2292</pub-id>, <pub-id pub-id-type="pmid">19123792</pub-id></mixed-citation></ref>
<ref id="ref104"><label>104.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhai</surname><given-names>Z</given-names></name> <name><surname>Li</surname><given-names>M</given-names></name> <name><surname>Yao</surname><given-names>H</given-names></name> <name><surname>Jiang</surname><given-names>Y</given-names></name></person-group>. <article-title>Integrating network pharmacology to investigate cinnamaldehyde's protective effect against oxaliplatin-induced neurotoxicity</article-title>. <source>J Vis Exp</source>. (<year>2025</year>) <volume>225</volume>:<fpage>e69013</fpage>. doi: <pub-id pub-id-type="doi">10.3791/69013</pub-id></mixed-citation></ref>
<ref id="ref105"><label>105.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name> <name><surname>Yang</surname><given-names>G</given-names></name> <name><surname>Liu</surname><given-names>M</given-names></name> <name><surname>Zhang</surname><given-names>Y</given-names></name> <name><surname>Xu</surname><given-names>H</given-names></name> <name><surname>Mazhar</surname><given-names>M</given-names></name></person-group>. <article-title>Cinnamaldehyde and its combination with deferoxamine ameliorate inflammation, ferroptosis and hematoma expansion after intracerebral hemorrhage in mice</article-title>. <source>J Neuroinflammation</source>. (<year>2025</year>) <volume>22</volume>:<fpage>45</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12974-025-03373-y</pub-id>, <pub-id pub-id-type="pmid">39985048</pub-id></mixed-citation></ref>
<ref id="ref106"><label>106.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vieira-Ara&#x00FA;jo</surname><given-names>FM</given-names></name> <name><surname>Macedo Rondon</surname><given-names>FC</given-names></name> <name><surname>Pinto Vieira</surname><given-names>&#x00CD;G</given-names></name> <name><surname>Pereira Mendes</surname><given-names>FN</given-names></name> <name><surname>de Carneiro Freitas</surname><given-names>JC</given-names></name> <name><surname>Maia Morais</surname><given-names>S</given-names></name></person-group>. <article-title>Sinergism between alkaloids piperine and capsaicin with meglumine antimoniate against <italic>Leishmania infantum</italic></article-title>. <source>Exp Parasitol</source>. (<year>2018</year>) <volume>188</volume>:<fpage>79</fpage>&#x2013;<lpage>82</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.exppara.2018.04.001</pub-id>, <pub-id pub-id-type="pmid">29625099</pub-id></mixed-citation></ref>
<ref id="ref107"><label>107.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>Y</given-names></name> <name><surname>Zhang</surname><given-names>C</given-names></name> <name><surname>Jiang</surname><given-names>X</given-names></name> <name><surname>Li</surname><given-names>X</given-names></name> <name><surname>Chen</surname><given-names>B</given-names></name> <name><surname>Jiang</surname><given-names>W</given-names></name></person-group>. <article-title>Capsiate attenuates atherosclerosis by activating Nrf2/GPX4 pathway and reshaping the intestinal microbiota in ApoE(&#x2212;/&#x2212;) mice</article-title>. <source>Microbiol Spectr</source>. (<year>2025</year>) <volume>13</volume>:<fpage>e0315524</fpage>. doi: <pub-id pub-id-type="doi">10.1128/spectrum.03155-24</pub-id>, <pub-id pub-id-type="pmid">40029381</pub-id></mixed-citation></ref>
<ref id="ref108"><label>108.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>X</given-names></name> <name><surname>Bian</surname><given-names>Z</given-names></name> <name><surname>Zhang</surname><given-names>M</given-names></name></person-group>. <article-title>Targeting the Nrf2 signaling pathway using phytochemical ingredients: a novel therapeutic road map to combat neurodegenerative diseases</article-title>. <source>Phytomedicine</source>. (<year>2023</year>) <volume>109</volume>:<fpage>154582</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.phymed.2022.154582</pub-id>, <pub-id pub-id-type="pmid">36610130</pub-id></mixed-citation></ref>
<ref id="ref109"><label>109.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdel-Salam</surname><given-names>OME</given-names></name> <name><surname>M&#x00F3;zsik</surname><given-names>G</given-names></name></person-group>. <article-title>Capsaicin, the Vanilloid receptor TRPV1 agonist in neuroprotection: mechanisms involved and significance</article-title>. <source>Neurochem Res</source>. (<year>2023</year>) <volume>48</volume>:<fpage>3296</fpage>&#x2013;<lpage>315</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11064-023-03983-z</pub-id>, <pub-id pub-id-type="pmid">37493882</pub-id></mixed-citation></ref>
<ref id="ref110"><label>110.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varshney</surname><given-names>V</given-names></name> <name><surname>Kumar</surname><given-names>A</given-names></name> <name><surname>Parashar</surname><given-names>V</given-names></name> <name><surname>Kumar</surname><given-names>A</given-names></name> <name><surname>Goyal</surname><given-names>A</given-names></name> <name><surname>Garabadu</surname><given-names>D</given-names></name></person-group>. <article-title>Therapeutic potential of capsaicin in various neurodegenerative diseases with special focus on Nrf2 signaling</article-title>. <source>Curr Pharm Biotechnol</source>. (<year>2024</year>) <volume>25</volume>:<fpage>1693</fpage>&#x2013;<lpage>707</lpage>. doi: <pub-id pub-id-type="doi">10.2174/0113892010277933231122111244</pub-id>, <pub-id pub-id-type="pmid">38173062</pub-id></mixed-citation></ref>
<ref id="ref111"><label>111.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>C</given-names></name> <name><surname>Guo</surname><given-names>W</given-names></name> <name><surname>He</surname><given-names>R</given-names></name> <name><surname>Meng</surname><given-names>X</given-names></name> <name><surname>Fu</surname><given-names>J</given-names></name> <name><surname>Lu</surname><given-names>Y</given-names></name></person-group>. <article-title>Dietary capsaicin attenuates cardiac injury after myocardial infarction in type 2 diabetic mice by inhibiting ferroptosis through activation of TRPV1 and Nrf2/HMOX1 pathway</article-title>. <source>Int Immunopharmacol</source>. (<year>2024</year>) <volume>140</volume>:<fpage>112852</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.intimp.2024.112852</pub-id>, <pub-id pub-id-type="pmid">39106715</pub-id></mixed-citation></ref>
<ref id="ref112"><label>112.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>XY</given-names></name> <name><surname>Yang</surname><given-names>Y</given-names></name> <name><surname>Jia</surname><given-names>XT</given-names></name> <name><surname>Jiang</surname><given-names>DL</given-names></name> <name><surname>Fu</surname><given-names>LY</given-names></name> <name><surname>Tian</surname><given-names>H</given-names></name> <etal/></person-group>. <article-title>Capsaicin pretreatment attenuates salt-sensitive hypertension by alleviating AMPK/Akt/Nrf2 pathway in hypothalamic paraventricular nucleus</article-title>. <source>Front Neurosci</source>. (<year>2024</year>) <volume>18</volume>:<fpage>1416522</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnins.2024.1416522</pub-id>, <pub-id pub-id-type="pmid">38872941</pub-id></mixed-citation></ref>
<ref id="ref113"><label>113.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nasrnezhad</surname><given-names>R</given-names></name> <name><surname>Halalkhor</surname><given-names>S</given-names></name> <name><surname>Sadeghi</surname><given-names>F</given-names></name> <name><surname>Pourabdolhossein</surname><given-names>F</given-names></name></person-group>. <article-title>Piperine improves experimental autoimmune encephalomyelitis (EAE) in Lewis rats through its neuroprotective, anti-inflammatory, and antioxidant effects</article-title>. <source>Mol Neurobiol</source>. (<year>2021</year>) <volume>58</volume>:<fpage>5473</fpage>&#x2013;<lpage>93</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s12035-021-02497-5</pub-id>, <pub-id pub-id-type="pmid">34338970</pub-id></mixed-citation></ref>
<ref id="ref114"><label>114.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haq</surname><given-names>IU</given-names></name> <name><surname>Imran</surname><given-names>M</given-names></name> <name><surname>Nadeem</surname><given-names>M</given-names></name> <name><surname>Tufail</surname><given-names>T</given-names></name> <name><surname>Gondal</surname><given-names>TA</given-names></name> <name><surname>Mubarak</surname><given-names>MS</given-names></name></person-group>. <article-title>Piperine: a review of its biological effects</article-title>. <source>Phytother Res</source>. (<year>2021</year>) <volume>35</volume>:<fpage>680</fpage>&#x2013;<lpage>700</lpage>. doi: <pub-id pub-id-type="doi">10.1002/ptr.6855</pub-id>, <pub-id pub-id-type="pmid">32929825</pub-id></mixed-citation></ref>
<ref id="ref115"><label>115.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roshanbakhsh</surname><given-names>H</given-names></name> <name><surname>Elahdadi Salmani</surname><given-names>M</given-names></name> <name><surname>Dehghan</surname><given-names>S</given-names></name> <name><surname>Nazari</surname><given-names>A</given-names></name> <name><surname>Javan</surname><given-names>M</given-names></name> <name><surname>Pourabdolhossein</surname><given-names>F</given-names></name></person-group>. <article-title>Piperine ameliorated memory impairment and myelin damage in lysolecethin induced hippocampal demyelination</article-title>. <source>Life Sci</source>. (<year>2020</year>) <volume>253</volume>:<fpage>117671</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.lfs.2020.117671</pub-id>, <pub-id pub-id-type="pmid">32335165</pub-id></mixed-citation></ref>
<ref id="ref116"><label>116.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hosseini</surname><given-names>H</given-names></name> <name><surname>Ghavidel</surname><given-names>F</given-names></name> <name><surname>Rajabian</surname><given-names>A</given-names></name> <name><surname>Homayouni-Tabrizi</surname><given-names>M</given-names></name> <name><surname>Majeed</surname><given-names>M</given-names></name> <name><surname>Sahebkar</surname><given-names>A</given-names></name></person-group>. <article-title>The effects of curcumin plus Piperine co-administration on inflammation and oxidative stress: a systematic review and Meta-analysis of randomized controlled trials</article-title>. <source>Curr Med Chem</source>. (<year>2025</year>) <volume>32</volume>:<fpage>4078</fpage>&#x2013;<lpage>94</lpage>. doi: <pub-id pub-id-type="doi">10.2174/0109298673260515240322074849</pub-id>, <pub-id pub-id-type="pmid">38561618</pub-id></mixed-citation></ref>
<ref id="ref117"><label>117.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shoba</surname><given-names>G</given-names></name> <name><surname>Joy</surname><given-names>D</given-names></name> <name><surname>Joseph</surname><given-names>T</given-names></name> <name><surname>Majeed</surname><given-names>M</given-names></name> <name><surname>Rajendran</surname><given-names>R</given-names></name> <name><surname>Srinivas</surname><given-names>PS</given-names></name></person-group>. <article-title>Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers</article-title>. <source>Planta Med</source>. (<year>1998</year>) <volume>64</volume>:<fpage>353</fpage>&#x2013;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1055/s-2006-957450</pub-id>, <pub-id pub-id-type="pmid">9619120</pub-id></mixed-citation></ref>
<ref id="ref118"><label>118.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heidari</surname><given-names>H</given-names></name> <name><surname>Bagherniya</surname><given-names>M</given-names></name> <name><surname>Majeed</surname><given-names>M</given-names></name> <name><surname>Sathyapalan</surname><given-names>T</given-names></name> <name><surname>Jamialahmadi</surname><given-names>T</given-names></name> <name><surname>Sahebkar</surname><given-names>A</given-names></name></person-group>. <article-title>Curcumin-piperine co-supplementation and human health: a comprehensive review of preclinical and clinical studies</article-title>. <source>Phytother Res</source>. (<year>2023</year>) <volume>37</volume>:<fpage>1462</fpage>&#x2013;<lpage>87</lpage>. doi: <pub-id pub-id-type="doi">10.1002/ptr.7737</pub-id>, <pub-id pub-id-type="pmid">36720711</pub-id></mixed-citation></ref>
<ref id="ref119"><label>119.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>T</given-names></name> <name><surname>Song</surname><given-names>M</given-names></name> <name><surname>Wu</surname><given-names>Y</given-names></name> <name><surname>Li</surname><given-names>Z</given-names></name> <name><surname>Zhang</surname><given-names>S</given-names></name> <name><surname>Fan</surname><given-names>X</given-names></name></person-group>. <article-title>Schisandrin B ameliorates Alzheimer's disease by suppressing neuronal ferroptosis and ensuing microglia M1 polarization</article-title>. <source>Phytomedicine</source>. (<year>2025</year>) <volume>142</volume>:<fpage>156780</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.phymed.2025.156780</pub-id>, <pub-id pub-id-type="pmid">40382817</pub-id></mixed-citation></ref>
<ref id="ref120"><label>120.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>C</given-names></name> <name><surname>Wu</surname><given-names>Z</given-names></name> <name><surname>Chen</surname><given-names>F</given-names></name> <name><surname>Dai</surname><given-names>C</given-names></name> <name><surname>Yang</surname><given-names>X</given-names></name> <name><surname>Ye</surname><given-names>S</given-names></name> <etal/></person-group>. <article-title>Regulation of Nrf2/GPX4 signaling pathway by hyperbaric oxygen protects against depressive behavior and cognitive impairment in a spinal cord injury rat model</article-title>. <source>CNS Neurosci Ther</source>. (<year>2025</year>) <volume>31</volume>:<fpage>e70421</fpage>. doi: <pub-id pub-id-type="doi">10.1111/cns.70421</pub-id>, <pub-id pub-id-type="pmid">40326167</pub-id></mixed-citation></ref>
<ref id="ref121"><label>121.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>L</given-names></name> <name><surname>Jiang</surname><given-names>X</given-names></name> <name><surname>Wei</surname><given-names>Y</given-names></name> <name><surname>Xie</surname><given-names>J</given-names></name> <name><surname>Yang</surname><given-names>L</given-names></name></person-group>. <article-title>Effects of ginger root extract on cognitive impairment and the Nrf2/GPX4/SLC7A11 signaling pathway in aluminum-exposed rats</article-title>. <source>Metab Brain Dis</source>. (<year>2024</year>) <volume>40</volume>:<fpage>60</fpage>. doi: <pub-id pub-id-type="doi">10.1007/s11011-024-01495-5</pub-id>, <pub-id pub-id-type="pmid">39661217</pub-id></mixed-citation></ref>
<ref id="ref122"><label>122.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>W</given-names></name> <name><surname>Zhou</surname><given-names>J</given-names></name></person-group>. <article-title>Icariside II suppresses ferroptosis to protect against MPP(+)-induced Parkinson's disease through Keap1/Nrf2/GPX4 signaling</article-title>. <source>Chin J Physiol</source>. (<year>2023</year>) <volume>66</volume>:<fpage>437</fpage>&#x2013;<lpage>45</lpage>. doi: <pub-id pub-id-type="doi">10.4103/cjop.cjop-d-23-00107</pub-id>, <pub-id pub-id-type="pmid">38149556</pub-id></mixed-citation></ref>
<ref id="ref123"><label>123.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>J</given-names></name> <name><surname>Conrad</surname><given-names>M</given-names></name></person-group>. <article-title>The metabolic underpinnings of Ferroptosis</article-title>. <source>Cell Metab</source>. (<year>2020</year>) <volume>32</volume>:<fpage>920</fpage>&#x2013;<lpage>37</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cmet.2020.10.011</pub-id>, <pub-id pub-id-type="pmid">33217331</pub-id></mixed-citation></ref>
<ref id="ref124"><label>124.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wegiel</surname><given-names>J</given-names></name> <name><surname>Flory</surname><given-names>M</given-names></name> <name><surname>Kuchna</surname><given-names>I</given-names></name> <name><surname>Nowicki</surname><given-names>K</given-names></name> <name><surname>Ma</surname><given-names>SY</given-names></name> <name><surname>Wegiel</surname><given-names>J</given-names></name> <etal/></person-group>. <article-title>Clinicopathological staging of dynamics of neurodegeneration and neuronal loss in Alzheimer disease</article-title>. <source>J Neuropathol Exp Neurol</source>. (<year>2021</year>) <volume>80</volume>:<fpage>21</fpage>&#x2013;<lpage>44</lpage>. doi: <pub-id pub-id-type="doi">10.1093/jnen/nlaa140</pub-id>, <pub-id pub-id-type="pmid">33270870</pub-id></mixed-citation></ref>
<ref id="ref125"><label>125.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balusu</surname><given-names>S</given-names></name> <name><surname>De Strooper</surname><given-names>B</given-names></name></person-group>. <article-title>The necroptosis cell death pathway drives neurodegeneration in Alzheimer's disease</article-title>. <source>Acta Neuropathol</source>. (<year>2024</year>) <volume>147</volume>:<fpage>96</fpage>. doi: <pub-id pub-id-type="doi">10.1007/s00401-024-02747-5</pub-id>, <pub-id pub-id-type="pmid">38852117</pub-id></mixed-citation></ref>
<ref id="ref126"><label>126.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ravindra</surname><given-names>J</given-names></name> <name><surname>Ug</surname><given-names>Y</given-names></name> <name><surname>Pandyanda Nanjappa</surname><given-names>D</given-names></name> <name><surname>Kalladka</surname><given-names>K</given-names></name> <name><surname>Dhakal</surname><given-names>R</given-names></name> <name><surname>Chakraborty</surname><given-names>A</given-names></name> <etal/></person-group>. <article-title>Allicin extracted from <italic>Allium sativum</italic> shows potent anti-cancer and antioxidant properties in zebrafish</article-title>. <source>Biomed Pharmacother</source>. (<year>2023</year>) <volume>169</volume>:<fpage>115854</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.biopha.2023.115854</pub-id>, <pub-id pub-id-type="pmid">37951024</pub-id></mixed-citation></ref>
<ref id="ref127"><label>127.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ou</surname><given-names>C</given-names></name> <name><surname>Bi</surname><given-names>X</given-names></name> <name><surname>Liu</surname><given-names>Y</given-names></name> <name><surname>Fu</surname><given-names>T</given-names></name> <name><surname>Ouyang</surname><given-names>Q</given-names></name> <name><surname>Li</surname><given-names>S</given-names></name> <etal/></person-group>. <article-title>Thermal degradation of capsaicin and dihydrocapsaicin: mechanism and hazards of volatile products</article-title>. <source>J Anal Appl Pyrolysis</source>. (<year>2024</year>) <volume>182</volume>:<fpage>106714</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jaap.2024.106714</pub-id></mixed-citation></ref>
<ref id="ref128"><label>128.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guri</surname><given-names>A</given-names></name> <name><surname>G&#x00FC;lseren</surname><given-names>&#x0130;</given-names></name> <name><surname>Arranz</surname><given-names>E</given-names></name> <name><surname>Corredig</surname><given-names>M</given-names></name></person-group>. <article-title>Delivery of curcumin using skim Milk or oil in water emulsions: effect of the matrices on cellular uptake</article-title>. <source>J Oleo Sci</source>. (<year>2018</year>) <volume>67</volume>:<fpage>641</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.5650/jos.ess17221</pub-id>, <pub-id pub-id-type="pmid">29760329</pub-id></mixed-citation></ref>
<ref id="ref129"><label>129.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bharmoria</surname><given-names>P</given-names></name> <name><surname>Bisht</surname><given-names>M</given-names></name> <name><surname>Gomes</surname><given-names>MC</given-names></name> <name><surname>Martins</surname><given-names>M</given-names></name> <name><surname>Neves</surname><given-names>MC</given-names></name> <name><surname>Mano</surname><given-names>JF</given-names></name> <etal/></person-group>. <article-title>Protein-olive oil-in-water nanoemulsions as encapsulation materials for curcumin acting as anticancer agent towards MDA-MB-231 cells</article-title>. <source>Sci Rep</source>. (<year>2021</year>) <volume>11</volume>:<fpage>9099</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-021-88482-3</pub-id>, <pub-id pub-id-type="pmid">33907277</pub-id></mixed-citation></ref>
<ref id="ref130"><label>130.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anand</surname><given-names>P</given-names></name> <name><surname>Kunnumakkara</surname><given-names>AB</given-names></name> <name><surname>Newman</surname><given-names>RA</given-names></name> <name><surname>Aggarwal</surname><given-names>BB</given-names></name></person-group>. <article-title>Bioavailability of curcumin: problems and promises</article-title>. <source>Mol Pharm</source>. (<year>2007</year>) <volume>4</volume>:<fpage>807</fpage>&#x2013;<lpage>18</lpage>. doi: <pub-id pub-id-type="doi">10.1021/mp700113r</pub-id>, <pub-id pub-id-type="pmid">17999464</pub-id></mixed-citation></ref>
<ref id="ref131"><label>131.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abd El-Hack</surname><given-names>ME</given-names></name> <name><surname>El-Saadony</surname><given-names>MT</given-names></name> <name><surname>Swelum</surname><given-names>AA</given-names></name> <name><surname>Arif</surname><given-names>M</given-names></name> <name><surname>Abo Ghanima</surname><given-names>MM</given-names></name> <name><surname>Shukry</surname><given-names>M</given-names></name> <etal/></person-group>. <article-title>Curcumin, the active substance of turmeric: its effects on health and ways to improve its bioavailability</article-title>. <source>J Sci Food Agric</source>. (<year>2021</year>) <volume>101</volume>:<fpage>5747</fpage>&#x2013;<lpage>62</lpage>. doi: <pub-id pub-id-type="doi">10.1002/jsfa.11372</pub-id>, <pub-id pub-id-type="pmid">34143894</pub-id></mixed-citation></ref>
<ref id="ref132"><label>132.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>J</given-names></name> <name><surname>Jia</surname><given-names>W</given-names></name> <name><surname>Zhang</surname><given-names>R</given-names></name> <name><surname>Wang</surname><given-names>X</given-names></name> <name><surname>Zhang</surname><given-names>L</given-names></name></person-group>. <article-title>Improving curcumin bioavailability: targeted delivery of curcumin and loading systems in intestinal inflammation</article-title>. <source>Food Res Int</source>. (<year>2024</year>) <volume>196</volume>:<fpage>115079</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.foodres.2024.115079</pub-id>, <pub-id pub-id-type="pmid">39614566</pub-id></mixed-citation></ref>
<ref id="ref133"><label>133.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Saadony</surname><given-names>MT</given-names></name> <name><surname>Saad</surname><given-names>AM</given-names></name> <name><surname>Mohammed</surname><given-names>DM</given-names></name> <name><surname>Alkafaas</surname><given-names>SS</given-names></name> <name><surname>Ghosh</surname><given-names>S</given-names></name> <name><surname>Negm</surname><given-names>SH</given-names></name> <etal/></person-group>. <article-title>Curcumin, an active component of turmeric: biological activities, nutritional aspects, immunological, bioavailability, and human health benefits &#x2013; a comprehensive review</article-title>. <source>Front Immunol</source>. (<year>2025</year>) <volume>16</volume>:<fpage>1603018</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2025.1603018</pub-id>, <pub-id pub-id-type="pmid">40918117</pub-id></mixed-citation></ref>
<ref id="ref134"><label>134.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rojo de la Vega</surname><given-names>M</given-names></name> <name><surname>Chapman</surname><given-names>E</given-names></name> <name><surname>Zhang</surname><given-names>DD</given-names></name></person-group>. <article-title>NRF2 and the hallmarks of Cancer</article-title>. <source>Cancer Cell</source>. (<year>2018</year>) <volume>34</volume>:<fpage>21</fpage>&#x2013;<lpage>43</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ccell.2018.03.022</pub-id>, <pub-id pub-id-type="pmid">29731393</pub-id></mixed-citation></ref>
<ref id="ref135"><label>135.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menegon</surname><given-names>S</given-names></name> <name><surname>Columbano</surname><given-names>A</given-names></name> <name><surname>Giordano</surname><given-names>S</given-names></name></person-group>. <article-title>The dual roles of NRF2 in Cancer</article-title>. <source>Trends Mol Med</source>. (<year>2016</year>) <volume>22</volume>:<fpage>578</fpage>&#x2013;<lpage>93</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.molmed.2016.05.002</pub-id>, <pub-id pub-id-type="pmid">27263465</pub-id></mixed-citation></ref>
<ref id="ref136"><label>136.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Godos</surname><given-names>J</given-names></name> <name><surname>Carota</surname><given-names>G</given-names></name> <name><surname>Caruso</surname><given-names>G</given-names></name> <name><surname>Micek</surname><given-names>A</given-names></name> <name><surname>Frias-Toral</surname><given-names>E</given-names></name> <name><surname>Giampieri</surname><given-names>F</given-names></name> <etal/></person-group>. <article-title>Molecular mechanisms underlying the neuroprotective effects of polyphenols: implications for cognitive function</article-title>. <source>EXCLI J</source>. (<year>2025</year>) <volume>24</volume>:<fpage>1262</fpage>&#x2013;<lpage>94</lpage>. doi: <pub-id pub-id-type="doi">10.17179/excli2025-8779</pub-id>, <pub-id pub-id-type="pmid">41078565</pub-id></mixed-citation></ref>
<ref id="ref137"><label>137.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name> <name><surname>Wang</surname><given-names>G</given-names></name> <name><surname>Kong</surname><given-names>Y</given-names></name> <name><surname>Xu</surname><given-names>H</given-names></name> <name><surname>Xiao</surname><given-names>B</given-names></name> <name><surname>Liu</surname><given-names>Y</given-names></name> <etal/></person-group>. <article-title>A comparative analysis of the essential oils from two species of garlic seedlings cultivated in China: chemical profile and anticoagulant potential</article-title>. <source>Food Funct</source>. (<year>2020</year>) <volume>11</volume>:<fpage>6020</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1039/d0fo00845a</pub-id>, <pub-id pub-id-type="pmid">32697212</pub-id></mixed-citation></ref>
<ref id="ref138"><label>138.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>S</given-names></name> <name><surname>Wang</surname><given-names>X</given-names></name> <name><surname>Xiao</surname><given-names>Y</given-names></name> <name><surname>Wang</surname><given-names>Y</given-names></name> <name><surname>Wan</surname><given-names>Y</given-names></name> <name><surname>Li</surname><given-names>X</given-names></name> <etal/></person-group>. <article-title>Curcumin ameliorates mercuric chloride-induced liver injury via modulating cytochrome P450 signaling and Nrf2/HO-1 pathway</article-title>. <source>Ecotoxicol Environ Saf</source>. (<year>2021</year>) <volume>208</volume>:<fpage>111426</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ecoenv.2020.111426</pub-id>, <pub-id pub-id-type="pmid">33096358</pub-id></mixed-citation></ref>
<ref id="ref139"><label>139.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mashayekhi-Sardoo</surname><given-names>H</given-names></name> <name><surname>Mashayekhi-Sardoo</surname><given-names>A</given-names></name> <name><surname>Roufogalis</surname><given-names>BD</given-names></name> <name><surname>Jamialahmadi</surname><given-names>T</given-names></name> <name><surname>Sahebkar</surname><given-names>A</given-names></name></person-group>. <article-title>Impact of curcumin on microsomal enzyme activities: drug interaction and Chemopreventive studies</article-title>. <source>Curr Med Chem</source>. (<year>2021</year>) <volume>28</volume>:<fpage>7122</fpage>&#x2013;<lpage>40</lpage>. doi: <pub-id pub-id-type="doi">10.2174/0929867328666210329123449</pub-id>, <pub-id pub-id-type="pmid">33781186</pub-id></mixed-citation></ref>
</ref-list>
<fn-group>
<fn fn-type="custom" custom-type="edited-by" id="fn0001">
<p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2724371/overview">Jianmei Li</ext-link>, Nanjing Normal University, China</p>
</fn>
<fn fn-type="custom" custom-type="reviewed-by" id="fn0002">
<p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/3343523/overview">Chengjie Duan</ext-link>, Army Medical University, China</p>
<p><ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/3344376/overview">Dehui Qian</ext-link>, Xinqiao Hospital, China</p>
</fn>
</fn-group>
<glossary>
<def-list>
<title>Glossary</title>
<def-item>
<term>A&#x03B2;</term>
<def>
<p>amyloid-&#x03B2;</p>
</def>
</def-item>
<def-item>
<term>&#x03B1;-syn</term>
<def>
<p>&#x03B1;-synuclein</p>
</def>
</def-item>
<def-item>
<term>ARES</term>
<def>
<p>antioxidant response elements</p>
</def>
</def-item>
<def-item>
<term>AD</term>
<def>
<p>Alzheimer&#x2019;s disease</p>
</def>
</def-item>
<def-item>
<term>ALS</term>
<def>
<p>Amyotrophic Lateral Sclerosis</p>
</def>
</def-item>
<def-item>
<term>ALOX15</term>
<def>
<p>arachidonate 15-lipoxygenase</p>
</def>
</def-item>
<def-item>
<term>ACSL4</term>
<def>
<p>Acyl-CoA synthetase long-chain family member 4</p>
</def>
</def-item>
<def-item>
<term>BBB</term>
<def>
<p>blood&#x2013;brain barrier</p>
</def>
</def-item>
<def-item>
<term>DAS</term>
<def>
<p>diallyl sulfide</p>
</def>
</def-item>
<def-item>
<term>DAQ</term>
<def>
<p>DAquinone</p>
</def>
</def-item>
<def-item>
<term>GCLM</term>
<def>
<p>glutamate-cysteine ligase modifier</p>
</def>
</def-item>
<def-item>
<term>FTH1</term>
<def>
<p>ferritin heavy chain 1</p>
</def>
</def-item>
<def-item>
<term>GSH</term>
<def>
<p>Glutathione</p>
</def>
</def-item>
<def-item>
<term>GPX4</term>
<def>
<p>glutathione peroxidase 4</p>
</def>
</def-item>
<def-item>
<term>HO-1</term>
<def>
<p>heme oxygenase 1</p>
</def>
</def-item>
<def-item>
<term>HD</term>
<def>
<p>Huntington&#x2019;s Disease</p>
</def>
</def-item>
<def-item>
<term>ICH</term>
<def>
<p>intracerebral hemorrhage</p>
</def>
</def-item>
<def-item>
<term>Keap1</term>
<def>
<p>Kelch-like ECH-associated protein 1</p>
</def>
</def-item>
<def-item>
<term>mtHtt</term>
<def>
<p>mutant huntingtin protein</p>
</def>
</def-item>
<def-item>
<term>NDs</term>
<def>
<p>neurodegenerative diseases</p>
</def>
</def-item>
<def-item>
<term>Nrf2</term>
<def>
<p>nuclear factor erythroid 2-related factor 2</p>
</def>
</def-item>
<def-item>
<term>SAC</term>
<def>
<p>S-allylcysteine</p>
</def>
</def-item>
<def-item>
<term>PD</term>
<def>
<p>Parkinson&#x2019;s disease</p>
</def>
</def-item>
<def-item>
<term>PUFAs</term>
<def>
<p>polyunsaturated fatty acids</p>
</def>
</def-item>
<def-item>
<term>ROS</term>
<def>
<p>reactive oxygen species</p>
</def>
</def-item>
</def-list>
</glossary>
</back>
</article>